<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">97106</article-id><article-id pub-id-type="doi">10.7554/eLife.97106</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.97106.4</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Brain-derived estrogens facilitate male-typical behaviors by potentiating androgen receptor signaling in medaka</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nishiike</surname><given-names>Yuji</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6586-6348</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Maki</surname><given-names>Shizuku</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Miyazoe</surname><given-names>Daichi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Nakasone</surname><given-names>Kiyoshi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kamei</surname><given-names>Yasuhiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6382-1365</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Todo</surname><given-names>Takeshi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ishikawa-Fujiwara</surname><given-names>Tomoko</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ohno</surname><given-names>Kaoru</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Usami</surname><given-names>Takeshi</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Nagahama</surname><given-names>Yoshitaka</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Okubo</surname><given-names>Kataaki</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4178-3094</contrib-id><email>a-okubo@g.ecc.u-tokyo.ac.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Department of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo</institution></institution-wrap><addr-line><named-content content-type="city">Bunkyo</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05q8wtt20</institution-id><institution>Optics and Bioimaging Facility, Trans-Scale Biology Center, National Institute for Basic Biology</institution></institution-wrap><addr-line><named-content content-type="city">Okazaki</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Department of Genome Biology, Graduate School of Medicine, Osaka University</institution></institution-wrap><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05q8wtt20</institution-id><institution>Division of Reproductive Biology, National Institute for Basic Biology</institution></institution-wrap><addr-line><named-content content-type="city">Okazaki</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Taffe</surname><given-names>Michael A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>University of California, San Diego</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taffe</surname><given-names>Michael A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0168r3w48</institution-id><institution>University of California, San Diego</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>13</day><month>01</month><year>2026</year></pub-date><volume>13</volume><elocation-id>RP97106</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-03-11"><day>11</day><month>03</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-02-16"><day>16</day><month>02</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.13.580203"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-06-06"><day>06</day><month>06</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97106.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-26"><day>26</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97106.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-12-15"><day>15</day><month>12</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.97106.3"/></event></pub-history><permissions><copyright-statement>© 2024, Nishiike et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Nishiike et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-97106-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-97106-figures-v1.pdf"/><abstract><p>In rodents, estrogens aromatized from androgens in the brain are essential for the development of male-typical behaviors. In many other vertebrates, including humans and teleost fish, however, androgens facilitate these behaviors directly via the androgen receptor without aromatization into estrogens. Here, we report that mutagenesis-derived male medaka fish lacking Cyp19a1b (a subtype of aromatase predominantly expressed in the brain) exhibit severely impaired male-typical mating and aggression, despite elevated brain androgen levels. These phenotypes can be rescued by estrogen administration, indicating that brain-derived estrogens are pivotal for male-typical behaviors even in teleosts. Our results further suggest that these estrogens facilitate male-typical behaviors by potentiating androgen action in the brain via the direct stimulation of androgen receptor transcription. Taken together, these findings reveal a previously unappreciated mode of action of brain-derived estrogens in facilitating male-typical behaviors.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>aggression</kwd><kwd>androgen receptor</kwd><kwd>aromatase</kwd><kwd>mating</kwd><kwd>brain-derived estrogens</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>21J20634</award-id><principal-award-recipient><name><surname>Nishiike</surname><given-names>Yuji</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hhkn466</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>23K26998</award-id><principal-award-recipient><name><surname>Okubo</surname><given-names>Kataaki</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048rj2z13</institution-id><institution>Ministry of Education, Culture, Sports, Science and Technology</institution></institution-wrap></funding-source><award-id>17H06429</award-id><principal-award-recipient><name><surname>Okubo</surname><given-names>Kataaki</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Regional Fish Institute</institution></institution-wrap></funding-source><award-id>Get-Research Grant</award-id><principal-award-recipient><name><surname>Okubo</surname><given-names>Kataaki</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Estrogens produced in the teleost brain increase neural sensitivity to testicular androgens by directly stimulating androgen receptor transcription, thereby eliciting male-typical behaviors.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Male and female animals exhibit differences in many innate behaviors, such as mating and aggression (<xref ref-type="bibr" rid="bib55">Zilkha et al., 2021</xref>). In vertebrates, these differences are driven primarily by the influence of sex steroid hormones, including estrogens and androgens. Extensive research in rodents has established that estrogens, traditionally considered ‘female’ hormones, are critical for the development of male-typical behaviors (<xref ref-type="bibr" rid="bib40">Ogawa et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Tsukahara and Morishita, 2020</xref>; <xref ref-type="bibr" rid="bib34">McCarthy, 2023</xref>). Specifically, androgens secreted by the testis, both perinatally and in adulthood, are converted to estrogens in the brain by the enzyme aromatase. These estrogens then act through ESR1, a subtype of the estrogen receptor (ESR), to elicit male-typical behaviors (<xref ref-type="bibr" rid="bib40">Ogawa et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Tsukahara and Morishita, 2020</xref>; <xref ref-type="bibr" rid="bib34">McCarthy, 2023</xref>). This process, originally referred to as the ‘aromatization hypothesis’, is now widely acknowledged; however, the mechanisms through which brain-derived estrogens affect male-typical behavior, including the identity of their downstream targets, remain largely elusive (<xref ref-type="bibr" rid="bib33">McCarthy et al., 2017</xref>; <xref ref-type="bibr" rid="bib34">McCarthy, 2023</xref>).</p><p>More importantly, the aromatization hypothesis seems to apply to only a limited number of species besides rodents (e.g. some birds such as zebra finches) (<xref ref-type="bibr" rid="bib5">Balthazart, 2019</xref>). In other species such as humans, other primates, and teleost fish, testicular androgens facilitate male-typical behaviors directly through the androgen receptor (AR) without aromatization (<xref ref-type="bibr" rid="bib48">Thornton et al., 2009</xref>; <xref ref-type="bibr" rid="bib4">Bakker, 2022</xref>; <xref ref-type="bibr" rid="bib43">Okubo et al., 2022</xref>). In primates, the hypothalamic aromatization of androgens to estrogens plays a central role in female gametogenesis (<xref ref-type="bibr" rid="bib47">Terasawa, 2018</xref>) but is not essential for male behaviors (<xref ref-type="bibr" rid="bib48">Thornton et al., 2009</xref>; <xref ref-type="bibr" rid="bib4">Bakker, 2022</xref>). Notably, in teleosts, 11-ketotestosterone (11KT), which cannot be aromatized to estrogens, is the primary testicular androgen, and exogenous 11KT effectively induces male-typical courtship and aggression even in females (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>; <xref ref-type="bibr" rid="bib43">Okubo et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Kawabata-Sakata et al., 2024</xref>). Therefore, it is generally assumed that, in teleosts, androgens are largely responsible for male-typical behaviors, while estrogens are dispensable for these behaviors. This is consistent with recent observations in a few teleost species that genetic ablation of AR severely impairs male-typical behaviors (<xref ref-type="bibr" rid="bib53">Yong et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Alward et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Ogino et al., 2023</xref>; <xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>) and with findings in medaka fish (<italic>Oryzias latipes</italic>) that estrogens act through the ESR subtype Esr2b to prevent females from engaging in male-typical courtship (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>).</p><p>Interestingly, despite these findings, adult teleost brains have extremely high levels of aromatase activity (100–1000 times higher than in rodent brains), resulting in large amounts of brain estrogens even in males (<xref ref-type="bibr" rid="bib10">Diotel et al., 2018</xref>). In teleost brains, including those of medaka, aromatase is exclusively localized in radial glial cells, in contrast to its neuronal localization in rodent brains (<xref ref-type="bibr" rid="bib12">Forlano et al., 2001</xref>; <xref ref-type="bibr" rid="bib9">Diotel et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Takeuchi and Okubo, 2013</xref>). These observations suggest that brain-derived estrogens have a vital, but as yet undetermined, role in male teleosts. It is worth mentioning that systemic administration of estrogens and an aromatase inhibitor increased and decreased male aggression, respectively, in several teleost species, potentially reflecting the behavioral effects of brain-derived estrogens (<xref ref-type="bibr" rid="bib14">Hallgren et al., 2006</xref>; <xref ref-type="bibr" rid="bib39">O’Connell and Hofmann, 2012</xref>; <xref ref-type="bibr" rid="bib17">Huffman et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Jalabert et al., 2015</xref>). Most teleost species have two distinct genes encoding aromatase, <italic>cyp19a1a</italic> and <italic>cyp19a1b</italic>, due to a whole-genome duplication that occurred early in teleost evolution (<xref ref-type="bibr" rid="bib10">Diotel et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Nagahama et al., 2021</xref>). These genes have undergone subfunctionalization through the partitioning of tissue-specific expression patterns: <italic>cyp19a1a</italic> is expressed predominantly in the gonad, whereas <italic>cyp19a1b</italic> is expressed in the brain (<xref ref-type="bibr" rid="bib10">Diotel et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Nagahama et al., 2021</xref>). In medaka, <italic>cyp19a1b</italic> is also expressed in the gonads, but only at a level tens to hundreds of times lower than in the brain and substantially lower than that of <italic>cyp19a1a</italic> (<xref ref-type="bibr" rid="bib42">Okubo et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Nakamoto et al., 2018</xref>).</p><p>In the present study, we generated <italic>cyp19a1b</italic>-deficient medaka, in which estrogen synthesis in the brain is selectively impaired while that in the gonads remains intact, in order to investigate the impact of brain-derived estrogens on male behaviors. Remarkably, the fish showed severely impaired male-typical behaviors, thus revealing the marked behavioral effects of these estrogens. Our results further suggest that these effects are mediated by potentiating androgen signaling in behaviorally relevant brain regions.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>cyp19a1b</italic>-deficient males exhibit severely impaired male-typical mating and aggressive behaviors</title><p>We generated a <italic>cyp19a1b</italic>-deficient medaka line from a mutant founder carrying a nonsense mutation in exon 4 of <italic>cyp19a1b</italic> that was identified through screening of the medaka TILLING (targeting-induced local lesions in genomes) library (<xref ref-type="bibr" rid="bib46">Taniguchi et al., 2006</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>). Loss of <italic>cyp19a1b</italic> function in these fish was verified by measuring brain and peripheral levels of sex steroids in males. As expected, brain estradiol-17β (E2) in homozygous mutants (<italic>cyp19a1b</italic><sup>−/−</sup>) was significantly reduced to 16% of the levels in wild-type (<italic>cyp19a1b</italic><sup>+/+</sup>) siblings (p=0.0037) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Brain E2 in heterozygotes (<italic>cyp19a1b</italic><sup>+/−</sup>) was also reduced to 45% of wild-type levels (p=0.0284) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), indicating a dosage effect of the <italic>cyp19a1b</italic> mutation. In contrast, peripheral E2 levels were unaltered in <italic>cyp19a1b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), consistent with the expected functioning of Cyp19a1b primarily in the brain. Strikingly, brain testosterone levels, as opposed to E2, increased 2.2-fold in <italic>cyp19a1b</italic><sup>−/−</sup> males relative to wild-type siblings (p=0.0006) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Similarly, brain 11KT levels increased 6.2-fold (p=0.0007) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). These results indicate that <italic>cyp19a1b</italic>-deficient males have reduced estrogen coupled with elevated androgen levels in the brain, confirming the loss of <italic>cyp19a1b</italic> function. They also suggest that the majority of estrogens in the male brain are synthesized locally in the brain. Peripheral 11KT levels also increased 3.7-fold in <italic>cyp19a1b</italic><sup>−/−</sup> males (p=0.0789) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), indicating peripheral influence in addition to central effects.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>cyp19a1b</italic>-deficient males exhibit severely impaired male-typical mating and aggressive behaviors.</title><p>(<bold>A, B</bold>) Levels of E2, testosterone, and 11-ketotestosterone (11KT) in the brain (<bold>A</bold>) and periphery (<bold>B</bold>) of adult <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males (n=3 per genotype). (<bold>C</bold>) Brain <italic>cyp19a1b</italic> transcript levels in <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males (n=6 per genotype). Mean value for <italic>cyp19a1b</italic><sup>+/+</sup> males was arbitrarily set to 1. (<bold>D</bold>) Setup for testing the mating behavior of <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males. (<bold>E</bold>) Latency of <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males (n=18 per genotype) to initiate each mating act toward the stimulus female. (<bold>F</bold>) Setup for testing mating behavior using an <italic>esr2b</italic>-deficient female as the stimulus. (<bold>G</bold>) Latency of <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males (n=16, 16, and 17, respectively) to initiate each mating act toward the <italic>esr2b</italic>-deficient female. (<bold>H</bold>) Number of each mating act performed. (<bold>I</bold>) Latency of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males and <italic>cyp19a1b</italic><sup>+/+</sup> females (n=15 each) to receive courtship displays from the <italic>esr2b</italic>-deficient female. (<bold>J</bold>) Setup for testing aggressive behavior among grouped males. (<bold>K</bold>) Total number of each aggressive act performed by <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males. Each data point represents the sum of acts recorded for the 4 males of the same genotype in a single tank (n=6, 7, and 6 tanks, respectively). Statistical differences were assessed by Bonferroni’s or Dunn’s post hoc test (<bold>A, B, C, H, K</bold>) and Gehan-Breslow-Wilcoxon test with Bonferroni’s correction (<bold>E, G, I</bold>). Error bars represent SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Generation of <italic>cyp19a1b</italic>-deficient medaka.</title><p>(<bold>A</bold>) Schematic of the <italic>cyp19a1b</italic> locus showing the location of the mutation identified by TILLING (targeting-induced local lesions in genomes). Each exon is numbered. Nucleotide sequences of the wild-type (<italic>cyp19a1b</italic><sup>+</sup>) and mutant (<italic>cyp19a1b</italic><sup>−</sup>) alleles at the mutation site are shown, with the substituted nucleotide in red. (<bold>B</bold>) Comparison of the amino acid sequences deduced from the <italic>cyp19a1b</italic><sup>+</sup> and <italic>cyp19a1b</italic><sup>−</sup> alleles. Amino acid numbers are shown on the right. Putative functional domains (membrane-spanning region [residues 21–34 of wild-type Cyp19a1b], I-helix region [287–321], Ozol’s peptide region [346–368], aromatic region [404–415], and heme-binding region [429–452]) are shaded in gray. Asterisks denote stop codons. (<bold>C</bold>) Predicted three-dimensional structures of wild-type (left) and mutant (right) Cyp19a1b proteins. Key structural features are annotated as follows: membrane helix (blue), aromatic region (red), and heme-binding loop (orange).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Loss of <italic>cyp19a1b</italic> function was further confirmed by measuring <italic>cyp19a1b</italic> transcript levels in the brain and by predicting the three-dimensional structure of the mutant protein. Real-time PCR revealed that transcript levels were reduced by half in <italic>cyp19a1b</italic><sup>+/−</sup> males and were nearly undetectable in <italic>cyp19a1b</italic><sup>−/−</sup> males, presumably as a result of nonsense-mediated mRNA decay (<xref ref-type="bibr" rid="bib30">Lindeboom et al., 2019</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). The wild-type protein, modeled by AlphaFold 3, exhibited a typical cytochrome P450 fold, including the membrane helix, aromatic region, and heme-binding loop, all arranged in the expected configuration (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). The mutant protein, in contrast, was severely truncated, retaining only the membrane helix (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). The absence of essential domains strongly indicates that the allele encodes a nonfunctional Cyp19a1b protein. Together, transcript and structural analyses consistently demonstrate that the mutation generated in this study causes a complete loss of <italic>cyp19a1b</italic> function.</p><p>Next, we investigated the mating behavior of <italic>cyp19a1b</italic>-deficient males (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The mating behavior of medaka follows a stereotypical sequence. It begins with the male approaching and closely following the female (following). The male then performs a courtship display, rapidly swimming in a circular pattern in front of the female. If the female is receptive, the male grasps her with his fins (wrapping), culminating in the simultaneous release of eggs and sperm (spawning) (<xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>). Because 11KT, the primary driver of male-typical behaviors in teleosts, was increased in <italic>cyp19a1b</italic>-deficient males, we predicted that these fish would engage more actively in mating. Nevertheless, <italic>cyp19a1b</italic><sup>−/−</sup> males showed significantly longer latencies to initiate wrappings (p=0.0033 versus <italic>cyp19a1b</italic><sup>+/+</sup>, p=0.0195 versus <italic>cyp19a1b</italic><sup>+/−</sup>) and to spawn (p=0.0051 versus <italic>cyp19a1b</italic><sup>+/+</sup>, p=0.0195 versus <italic>cyp19a1b</italic><sup>+/−</sup>) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). These results suggest that they are less motivated to mate, though an alternative interpretation that their cognition or sexual preference may be altered cannot be dismissed.</p><p>However, no significant differences were evident in latencies to initiate followings and courtship displays (<xref ref-type="fig" rid="fig1">Figure 1E</xref>); therefore, the possibility that <italic>cyp19a1b</italic>-deficient males are less sexually attractive and less preferred by females could not be ruled out. To ascertain whether <italic>cyp19a1b</italic>-deficient males are indeed less motivated to mate, we further tested their mating behavior using <italic>esr2b</italic>-deficient females, which are unreceptive to male courtship (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>), as stimulus females (<xref ref-type="fig" rid="fig1">Figure 1F</xref>); this test eliminates the influence of female receptivity, facilitating an exclusive evaluation of male motivation to mate with females (<xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>). We found that <italic>cyp19a1b</italic><sup>−/−</sup> males showed significantly longer latencies to initiate followings (p=0.0129 versus <italic>cyp19a1b</italic><sup>+/+</sup>, p=0.0060 versus <italic>cyp19a1b</italic><sup>+/−</sup>), courtship displays (p=0.0003 versus <italic>cyp19a1b</italic><sup>+/+</sup>, p=0.0006 versus <italic>cyp19a1b</italic><sup>+/−</sup>), and wrapping attempts (p=0.0009 versus <italic>cyp19a1b</italic><sup>+/+</sup>, p=0.0282 versus <italic>cyp19a1b</italic><sup>+/−</sup>) (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). In addition, they exhibited significantly fewer courtship displays (p&lt;0.0001 versus both <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>+/−</sup>) and wrapping attempts (p&lt;0.0001 versus both <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>+/−</sup>) (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). These results thus confirmed that <italic>cyp19a1b</italic>-deficient males are less motivated to mate. In our previous study, we found that <italic>esr2b</italic>-deficient females court females preferentially over males (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>). Consistent with that finding, here, we observed that 12 of 15 <italic>cyp19a1b</italic><sup>+/+</sup> females received courtship displays from the <italic>esr2b</italic>-deficient female, as compared with only 2 of 15 <italic>cyp19a1b</italic><sup>+/+</sup> males (p=0.0003) (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). Curiously, we further observed that 8 of 15 <italic>cyp19a1b</italic><sup>−/−</sup> males received courtship displays from the <italic>esr2b</italic>-deficient female (p=0.0321 versus <italic>cyp19a1b</italic><sup>+/+</sup> males) (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). Perhaps <italic>cyp19a1b</italic><sup>−/−</sup> males are misidentified as females by <italic>esr2b</italic>-deficient females because they are reluctant to court or they exhibit some female-like behavior.</p><p>Next, we examined the intrasexual aggressive behavior of <italic>cyp19a1b</italic>-deficient males (<xref ref-type="fig" rid="fig1">Figure 1J</xref>). The aggressive behavior of teleosts including medaka consists of five types of behavioral acts: chases, fin displays, circles, strikes, and bites (<xref ref-type="bibr" rid="bib51">Yamashita et al., 2020</xref>). <italic>cyp19a1b</italic><sup>−/−</sup> males exhibited all of these aggressive acts less frequently than <italic>cyp19a1b</italic><sup>+/+</sup> and/or <italic>cyp19a1b</italic><sup>+/−</sup> males, with significant differences observed for chases (p=0.0123 versus <italic>cyp19a1b</italic><sup>+/−</sup>), fin displays (p=0.0214 versus <italic>cyp19a1b</italic><sup>+/+</sup>), and bites (p=0.0015 versus <italic>cyp19a1b</italic><sup>+/+</sup>, p=0.0002 versus <italic>cyp19a1b</italic><sup>+/−</sup>) (<xref ref-type="fig" rid="fig1">Figure 1K</xref>). These observations demonstrate that <italic>cyp19a1b</italic>-deficient males are less aggressive toward other males.</p><p>In tilapia (<italic>Oreochromis niloticus</italic>), depletion of <italic>cyp19a1b</italic> has been reported to cause male infertility due to efferent duct obstruction (<xref ref-type="bibr" rid="bib54">Zhang et al., 2019</xref>). If this is also the case in medaka, the observed behavioral defects might be secondary to infertility, possibly due to the perception of impaired sperm release. We therefore investigated the fertilization and hatching success of embryos derived from mating between <italic>cyp19a1b</italic><sup>−/−</sup> males and wild-type females. Their fertilization and hatching rates were 88.5% (n=183) and 93.2% (n=162), respectively, indicating that <italic>cyp19a1b</italic>-deficient male medaka have normal fertility.</p></sec><sec id="s2-2"><title>Brain-derived estrogens facilitate male-typical behaviors probably by stimulating brain AR expression</title><p>We considered that the impaired male-typical behaviors of <italic>cyp19a1b</italic>-deficient males might be reasonably attributed to either reduced E2 or increased 11KT in the brain. The latter possibility seemed unlikely because 11KT/AR signaling strongly promotes male-typical behaviors in teleosts (<xref ref-type="bibr" rid="bib53">Yong et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Alward et al., 2020</xref>; <xref ref-type="bibr" rid="bib43">Okubo et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Ogino et al., 2023</xref>; <xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>); therefore, we tested the former possibility by examining whether E2 treatment would rescue the behavioral phenotypes of <italic>cyp19a1b</italic>-deficient males (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). E2 treatment, while having no effect in <italic>cyp19a1b</italic><sup>+/+</sup> males (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>), significantly shortened the latency to (p=0.0005) and increased the number of (p=0.0006) courtship displays in <italic>cyp19a1b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). These results suggest that reduced E2 in the brain is the primary cause of the mating defects, highlighting a pivotal role of brain-derived estrogens in male mating behavior. However, caution is warranted, as an indirect peripheral effect of bath-immersed E2 on behavior cannot be ruled out, although this is unlikely given the comparable peripheral E2 levels in <italic>cyp19a1b</italic>-deficient and wild-type males. In contrast to mating, E2 treatment was not effective in restoring aggression in <italic>cyp19a1b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). It is possible that the treatment protocol used may have failed to replicate the estrogenic milieu necessary to induce aggression in males.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Brain-derived estrogens facilitate male-typical behaviors probably by stimulating brain AR expression.</title><p>(<bold>A</bold>) Setup for testing the mating behavior of E2-treated <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males. (<bold>B</bold>) Latency of <italic>cyp19a1b</italic><sup>+/+</sup> males (n=12) to initiate courtship displays toward the stimulus female before (day 0) and after (day 4) E2 treatment. (<bold>C</bold>) Number of courtship displays performed by <italic>cyp19a1b</italic><sup>+/+</sup> males. (<bold>D</bold>) Latency of <italic>cyp19a1b</italic><sup>−/−</sup> males to initiate courtship displays before (day 0; n=12) and after (day 4; n=11) E2 treatment. (<bold>E</bold>) Number of courtship displays performed by <italic>cyp19a1b</italic><sup>−/−</sup> males. (<bold>F</bold>) Total area of <italic>ara</italic> expression signal in each brain nucleus of <italic>cyp19a1b</italic><sup>+/+</sup> (n=6 except for pPPp, where n=5) and <italic>cyp19a1b</italic><sup>−/−</sup> (n=7) males. The data are displayed in two graphs for visual clarity. (<bold>G</bold>) Representative images of <italic>ara</italic> expression in the PPa, pPPp, and NVT. (<bold>H</bold>) Total area of <italic>arb</italic> expression signal in each brain nucleus of <italic>cyp19a1b</italic><sup>+/+</sup> (n=6) and <italic>cyp19a1b</italic><sup>−/−</sup> (n=7) males. The data are displayed in two graphs for visual clarity. (<bold>I</bold>) Representative images of <italic>arb</italic> expression in the PMp, aPPp, and NPT. (<bold>J</bold>) Total area of <italic>ara</italic> expression signal in the PPa, pPPp, and NVT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males treated with vehicle alone or E2 (n=5 per group except for NVT of E2-treated <italic>cyp19a1b</italic><sup>+/+</sup> males, where n=4; and PPa of vehicle-treated <italic>cyp19a1b</italic><sup>+/+</sup>, E2-treated <italic>cyp19a1b</italic><sup>+/+</sup>, and vehicle-treated <italic>cyp19a1b</italic><sup>−/−</sup> males, where n=3). (<bold>K</bold>) Total area of <italic>arb</italic> expression signal in the PMp, aPPp, and NPT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males treated with vehicle alone or E2 (n=5 per group except for NPT of vehicle-treated <italic>cyp19a1b</italic><sup>+/+</sup> males, where n=4). Scale bars represent 50 μm. For abbreviations of brain nuclei, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Statistical differences were assessed by Gehan-Breslow-Wilcoxon test (<bold>B, D</bold>) and unpaired <italic>t</italic> test, with Welch’s correction where appropriate (<bold>C, E, F, H, J, K</bold>). Error bars represent SEM. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Effect of estrogen replacement on aggression and brain <italic>ara</italic> and <italic>arb</italic> expression in <italic>cyp19a1b</italic>-deficient males.</title><p>(<bold>A</bold>) Total number of each aggressive act observed among <italic>cyp19a1b</italic><sup>+/+</sup> or <italic>cyp19a1b</italic><sup>−/−</sup> males before (day 0; n=6 and 5, respectively) or after (day 4; n=5 and 4, respectively) E2 treatment. (<bold>B</bold>) Total area of <italic>ara</italic> expression signal in the Vs/Vp, PMp, PMm/PMg/aPPp, VM, NAT, and NPT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males treated with vehicle alone or E2 (n=5 per group except for Vs/Vp of vehicle- and E2-treated <italic>cyp19a1b</italic><sup>+/+</sup> males, PMp and NPT of E2-treated <italic>cyp19a1b</italic><sup>+/+</sup> males, and VM of all males, where n=4). (<bold>C</bold>) Total area of <italic>arb</italic> expression signal in the Vv, Vs/Vp, PPa, pPPp, and NVT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males treated with vehicle alone or E2 (n=5 per group except for NVT of vehicle-treated <italic>cyp19a1b</italic><sup>+/+</sup> males, where n=4; and Vv of vehicle- and E2-treated <italic>cyp19a1b</italic><sup>−/−</sup> males, where n=3). For abbreviations of brain nuclei, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Statistical differences were assessed by unpaired <italic>t</italic> test, with Welch’s correction where appropriate (<bold>A, B, C</bold>). Error bars represent SEM. *p&lt;0.05, **p&lt;0.01.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Effect of estrogen replacement on brain <italic>ara</italic> and <italic>arb</italic> expression in <italic>cyp19a1b</italic>-deficient males.</title><p>(<bold>A</bold>) Representative images of <italic>ara</italic> expression in the Vs/Vp, PMp, PPa, PMm/PMg/aPPp, pPPp, NAT, NVT, and NPT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males treated with vehicle alone or E2. (<bold>B</bold>) Representative images of <italic>arb</italic> expression in the Vs/Vp, PMp, PPa, aPPp, pPPp, NVT, and NPT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males treated with vehicle alone or E2. Scale bars represent 50 μm. For abbreviations of brain nuclei, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig2-figsupp2-v1.tif"/></fig></fig-group><p>We then considered the mechanism by which brain-derived estrogens facilitate male-typical behaviors. Our previous study showed that exogenous E2 upregulates the expression of a subtype of AR, Ara, in the medaka brain (<xref ref-type="bibr" rid="bib15">Hiraki et al., 2012</xref>; note that Ara was termed Arb in this reference). We therefore hypothesized that brain-derived estrogens may facilitate male-typical behaviors by stimulating Ara expression and thereby potentiating 11KT/Ara signaling in the brain. To test this hypothesis, we first examined <italic>ara</italic> expression in the brain of <italic>cyp19a1b</italic>-deficient males by in situ hybridization analysis. Expression of <italic>ara</italic> was significantly lower in <italic>cyp19a1b</italic><sup>−/−</sup> males than in <italic>cyp19a1b</italic><sup>+/+</sup> males in several preoptic and hypothalamic nuclei that are activated upon mating and/or attack in males (<xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>), including the PPa, pPPp, and NVT (p=0.0134, 0.0372, and 0.0008, respectively) (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for abbreviations of brain nuclei). We then performed a similar analysis for the other AR subtype, Arb. Expression of <italic>arb</italic> was significantly lower in <italic>cyp19a1b</italic><sup>−/−</sup> than in <italic>cyp19a1b</italic><sup>+/+</sup> males in other preoptic and hypothalamic nuclei activated upon mating and/or attack (<xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>), including the PMp, aPPp, and NPT (p=0.0009, 0.0413, and 0.0021, respectively) (<xref ref-type="fig" rid="fig2">Figure 2H and I</xref>).</p><p>Next, to determine whether these reductions in <italic>ara</italic> and <italic>arb</italic> expression in <italic>cyp19a1b</italic><sup>−/−</sup> males were the result of reduced brain E2, we tested whether E2 treatment could restore the expression of the two genes. In situ hybridization revealed significantly increased <italic>ara</italic> and <italic>arb</italic> expression in most brain nuclei of E2-treated <italic>cyp19a1b</italic><sup>−/−</sup> males as compared with vehicle-treated <italic>cyp19a1b</italic><sup>−/−</sup> males (similar results were obtained in <italic>cyp19a1b</italic><sup>+/+</sup> males) (<xref ref-type="fig" rid="fig2">Figure 2J and K</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B and C</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), indicating that the decreased <italic>ara</italic> and <italic>arb</italic> expression in <italic>cyp19a1b</italic><sup>−/−</sup> males is attributable to reduced E2 levels. Taken together, these results suggest that brain-derived estrogens elicit male-typical behaviors by stimulating <italic>ara</italic> and <italic>arb</italic> expression in behaviorally relevant brain regions.</p></sec><sec id="s2-3"><title><italic>cyp19a1b</italic> deficiency impairs behaviorally relevant signaling pathways downstream of ARs</title><p>We considered that, if our hypothesis that brain-derived estrogens facilitate male-typical behaviors by potentiating androgen/AR signaling is correct, then <italic>cyp19a1b</italic>-deficient males should have impaired activation of behaviorally relevant genes that act downstream of ARs. Two neuropeptide genes, <italic>vt</italic> (encoding vasotocin) and <italic>gal</italic> (encoding galanin), have been implicated in male-typical mating and aggressive behaviors in various vertebrates, including medaka and other teleosts (<xref ref-type="bibr" rid="bib52">Yokoi et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Tripp et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Yamashita et al., 2020</xref>; <xref ref-type="bibr" rid="bib23">Kawabata-Sakata et al., 2024</xref>; <xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>). In medaka, subsets of neurons in the pNVT and pPMp express <italic>vt</italic> and <italic>gal</italic>, respectively, in an androgen-dependent and hence male-biased manner, and these neurons have been implicated in male-typical behaviors (<xref ref-type="bibr" rid="bib21">Kawabata et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Yamashita et al., 2020</xref>; <xref ref-type="bibr" rid="bib23">Kawabata-Sakata et al., 2024</xref>). We therefore studied the expression of <italic>vt</italic> and <italic>gal</italic> in the brains of <italic>cyp19a1b</italic>-deficient males.</p><p>In situ hybridization revealed that, as expected, expression of <italic>vt</italic> in the pNVT of <italic>cyp19a1b</italic><sup>−/−</sup> males was significantly reduced to 18% as compared with <italic>cyp19a1b</italic><sup>+/+</sup> males (p=0.0040) (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). In contrast, there were no significant differences between genotypes in other brain nuclei (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Similarly, expression of <italic>gal</italic> in the pPMp of <italic>cyp19a1b</italic><sup>−/−</sup> males was reduced to 43% as compared with <italic>cyp19a1b</italic><sup>+/+</sup> males (p=0.0019), while no significant differences were observed in other brain nuclei (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>). These results demonstrate that <italic>cyp19a1b</italic> deficiency severely impairs the AR-dependent activation of behaviorally relevant <italic>vt</italic> and <italic>gal</italic> expression, suggesting that brain-derived estrogens play a substantial role in activating AR signaling.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>cyp19a1b</italic> deficiency impairs behaviorally relevant signaling pathways downstream of ARs.</title><p>(<bold>A</bold>) Total area of <italic>vt</italic> expression signal in the PMp/PPa/PMm/PMg, SC/aNVT, and pNVT of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males (n=4 per genotype). (<bold>B</bold>) Representative images of <italic>vt</italic> expression in the pNVT. (<bold>C</bold>) Total area of <italic>gal</italic> expression signal in the aPMp/PPa, pPMp, PPp, and NAT/NVT/NRL of <italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males (n=3 and 4, respectively). (<bold>D</bold>) Representative images of <italic>gal</italic> expression in the pPMp. Scale bars represent 50 μm. For abbreviations of brain nuclei, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Statistical differences were assessed by unpaired <italic>t</italic> test, with Welch’s correction where appropriate (<bold>A, C</bold>). Error bars represent SEM. **p&lt;0.01.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>Estrogens directly stimulate the transcription of ARs through ESRs</title><p>The above results led us to further explore how brain-derived estrogens stimulate the expression of <italic>ara</italic> and <italic>arb</italic>. In silico analysis of the medaka <italic>ara</italic> and <italic>arb</italic> loci identified two canonical bipartite estrogen-responsive element (ERE)-like sequences in introns 1 and 2 of <italic>ara</italic> (located at positions +1699 and +2050, respectively, relative to the transcription initiation site) and three in the 5′-flanking region of <italic>arb</italic> (at positions –1272, –2180, and –3327) (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). Thus, brain estrogens might be able to directly activate the transcription of <italic>ara</italic> and <italic>arb</italic>. To evaluate this likelihood, we conducted in vitro transcriptional activity assays in which luciferase expression was driven by genomic fragments from the <italic>ara</italic> and <italic>arb</italic> loci containing the identified ERE-like sequences.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Estrogens directly stimulate the transcription of ARs through ESRs.</title><p>(<bold>A, B</bold>) Schematic of <italic>ara</italic> (<bold>A</bold>) and <italic>arb</italic> (<bold>B</bold>) loci showing the location of the canonical bipartite ERE-like sequences. Bent arrows mark the transcription initiation sites. Nucleotides of the ERE-like sequences are denoted by capital letters, and those identical to the consensus ERE (AGGTCAnnnTGACCT) are gray-shaded. (<bold>C</bold>) Ability of E2 to directly activate <italic>ara</italic> transcription. Cultured cells were transfected with a luciferase reporter construct containing a genomic fragment upstream of exon 3 of <italic>ara</italic>, together with an Esr1, Esr2a, or Esr2b expression construct. The cells were stimulated with different concentrations of E2, and luciferase activity was measured. (<bold>D</bold>) Effect of mutations in the ERE-like sequences on the E2-induced activation of <italic>ara</italic> transcription. Cultured cells were transfected with a wild-type luciferase construct or a construct carrying a mutation in the ERE-like sequence at position +1699 (mut +1699) or +2050 (mut+2050), together with an Esr1, Esr2a, or Esr2b expression construct. The cells were stimulated with or without E2, and luciferase activity was measured. (<bold>E</bold>) Ability of E2 to directly activate <italic>arb</italic> transcription. The assay described in C was performed with a luciferase construct containing a genomic fragment upstream of the first methionine codon of <italic>arb</italic>. (<bold>F</bold>) Effect of mutations in the ERE-like sequences on the E2-induced activation of <italic>arb</italic> transcription. The assay described in D was performed with luciferase constructs, each carrying a mutation in the ERE-like sequence at position –1272 (mut–1272), –2180 (mut–2180), or –3327 (mut–3327). Values are expressed as a fold change relative to a control without E2 stimulation (<bold>C, E</bold>) or a control using the wild-type construct without E2 stimulation (<bold>D, F</bold>). Statistical differences were assessed by Dunnett’s post hoc test (<bold>C, E</bold>) and unpaired <italic>t</italic> test with Bonferroni-Dunn correction (<bold>D, F</bold>). Error bars represent SEM. **p&lt;0.01; ***p&lt;0.001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Effect of mutations in each half-site of the identified estrogen-responsive element (ERE) on the E2-induced activation of <italic>ara</italic> and <italic>arb</italic> transcription.</title><p>(<bold>A</bold>) Effect of mutations in each half-site of the ERE at position +2050 of the <italic>ara</italic> locus on the E2-induced activation of <italic>ara</italic> transcription. Cultured cells were transfected with a wild-type luciferase reporter construct or a construct carrying a mutation in the 5′ (mut+2050–5′) or 3′ (mut+2050–3′) half-site of the ERE, together with an Esr1, Esr2a, or Esr2b expression construct. The cells were stimulated with or without E2, and luciferase activity was measured. (<bold>B</bold>) Effect of mutations in each half-site of the ERE at position –3327 of the <italic>arb</italic> locus on the E2-induced activation of <italic>arb</italic> transcription. Cultured cells were transfected with a wild-type luciferase construct or a construct carrying a mutation in the 5′ (mut–3327–5′) or 3′ (mut–3327–3′) half-site of the ERE, together with an Esr1, Esr2a, or Esr2b expression construct. The cells were stimulated with or without E2, and luciferase activity was measured. Values are represented relative to the wild-type construct without E2 stimulation. Statistical differences were assessed by unpaired <italic>t</italic> test with Bonferroni-Dunn correction (<bold>A, B</bold>). Error bars represent SEM. ***p&lt;0.001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig4-figsupp1-v1.tif"/></fig></fig-group><p>An assay using the <italic>ara</italic> genomic fragment revealed that E2 dose-dependently increased luciferase activity in the presence of any ESR subtype (Esr1, Esr2a, or Esr2b) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), suggesting that E2 has the ability to directly activate <italic>ara</italic> transcription through ESRs. The introduction of a point mutation into the ERE-like sequence at position +2050 abolished the E2-induced luciferase activity in the presence of any ESR subtype, while mutation at +1699 had no such effect (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These results suggest that the ERE at position +2050 is responsible for E2-induced activation of <italic>ara</italic> transcription. Because there is evidence that a single ERE half-site is sufficient to confer E2 responsiveness on several genes (<xref ref-type="bibr" rid="bib28">Klinge, 2001</xref>), we performed the assay using <italic>ara</italic> genomic fragments in which a mutation was introduced in either half-site of the ERE at +2050. E2 induction of luciferase activity was abrogated in both cases (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), suggesting that both ERE half-sites are required to confer estrogen responsiveness on <italic>ara</italic>.</p><p>In the assay using the <italic>arb</italic> genomic fragment, E2 also dose-dependently increased luciferase activity in the presence of any ESR subtype (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). The E2-induced increase was completely abolished by point mutation of the ERE-like sequence at position –3327 in the presence of any ESR subtype (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). A similar effect was observed for mutation of the ERE-like sequence at position –1272, but only in the presence of Esr1 and not in the presence of Esr2a or Esr2b (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). These results indicate that E2 can directly stimulate <italic>arb</italic> transcription, primarily through the ERE at –3327. Mutations in either half-site of this ERE eliminated induction by E2 in the presence of Esr2a or Esr2b, but not Esr1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>), suggesting that both ERE half-sites are required to confer estrogen responsiveness on <italic>arb</italic>. Collectively, these experiments suggest that the transcription of <italic>ara</italic> and <italic>arb</italic> can be directly stimulated by estrogens (including brain-derived estrogens) via the binding of ESRs to canonical bipartite EREs.</p></sec><sec id="s2-5"><title>Brain-derived estrogens stimulate <italic>ara</italic> and <italic>arb</italic> expression in behaviorally relevant brain regions primarily through Esr2a and Esr1, respectively</title><p>Next, we investigated whether brain-derived estrogens can induce <italic>ara</italic> and <italic>arb</italic> expression through ESRs in vivo and, if so, which ESR subtype (Esr1, Esr2a, or Esr2b) mediates this induction. To this end, we examined <italic>ara</italic> and <italic>arb</italic> expression in the brains of males deficient for each ESR subtype by in situ hybridization. We used previously described <italic>esr1</italic>- and <italic>esr2b</italic>-deficient medaka (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>; <xref ref-type="bibr" rid="bib11">Fleming et al., 2023</xref>) and generated <italic>esr2a</italic>-deficient medaka using the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system. Two independent <italic>esr2a</italic>-deficient lines (Δ8 and Δ4) were established (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) and used for subsequent behavioral experiments to ensure the reproducibility of the observed phenotypes.</p><p>In <italic>esr1</italic><sup>+/+</sup> and <italic>esr1</italic><sup>−/−</sup> males, <italic>ara</italic> expression was not significantly different between genotypes in any brain nucleus (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>), but <italic>arb</italic> expression was significantly lower in <italic>esr1</italic><sup>−/−</sup> than in <italic>esr1</italic><sup>+/+</sup> males in the PMp and aPPp (p=0.0111 and 0.0376, respectively) (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). This, together with our observation that <italic>arb</italic> expression in these brain nuclei was also significantly lower in <italic>cyp19a1b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), suggests that brain-derived estrogens stimulate <italic>arb</italic> expression in these nuclei primarily through Esr1. In support of this notion, double-label in situ hybridization in the wild-type male brain detected neurons coexpressing <italic>arb</italic> and <italic>esr1</italic> in both the PMp and aPPp (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>). In <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> male brains (from the Δ8 line), <italic>ara</italic> expression was significantly lower in <italic>esr2a</italic><sup>−/−</sup> than in <italic>esr2a</italic><sup>+/+</sup> males in the PPa, pPPp, and NVT (p=0.0359, 0.0430, and 0.0178, respectively) (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>), while no significant difference was observed in <italic>arb</italic> expression (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C</xref>). Considering that <italic>ara</italic> expression in these nuclei was also lower in <italic>cyp19a1b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), brain-derived estrogens presumably stimulate <italic>ara</italic> expression in these nuclei mainly through Esr2a. This idea was further supported by double-label in situ hybridization, which detected neurons coexpressing <italic>ara</italic> and <italic>esr2a</italic> in the PPa, pPPp, and NVT of wild-type males (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2D</xref>). Examination of <italic>esr2b</italic><sup>+/+</sup> and <italic>esr2b</italic><sup>−/−</sup> male brains showed significantly lower expression of <italic>ara</italic> in the NAT and higher expression of <italic>arb</italic> in the PPa of <italic>esr2b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2E–H</xref>); however, no such changes in expression were observed in <italic>cyp19a1b</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig2">Figure 2F and H</xref>). It therefore seems unlikely that Esr2b mediates the effect of brain estrogens on AR expression. Collectively, these results suggest that brain-derived estrogens stimulate <italic>ara</italic> and <italic>arb</italic> expression in behaviorally relevant brain regions primarily through Esr2a and Esr1, respectively.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Brain-derived estrogens stimulate <italic>ara</italic> and <italic>arb</italic> expression in behaviorally relevant brain regions primarily through Esr2a and Esr1, respectively.</title><p>(<bold>A</bold>) Total area of <italic>arb</italic> expression signal in each brain nucleus of <italic>esr1</italic><sup>+/+</sup> and <italic>esr1</italic><sup>−/−</sup> males (n=5 per genotype). The data are displayed in two graphs for visual clarity. (<bold>B</bold>) Representative images of <italic>arb</italic> expression in the PMp and aPPp. (<bold>C</bold>) Total area of <italic>ara</italic> expression signal in each brain nucleus of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males (Δ8 line; n=5 per genotype except for NPT of <italic>esr2a</italic><sup>+/+</sup> males and Vs/Vp and PMp of <italic>esr2a</italic><sup>−/−</sup> males, where n=4). The data are displayed in two graphs for visual clarity. (<bold>D</bold>) Representative images of <italic>ara</italic> expression in the PPa, pPPp, and NVT. (<bold>E</bold>) Setup for testing the mating behavior of <italic>esr1</italic><sup>+/+</sup> and <italic>esr1</italic><sup>−/−</sup> males using an <italic>esr2b</italic>-deficient female as the stimulus. (<bold>F</bold>) Latency of <italic>esr1</italic><sup>+/+</sup> and <italic>esr1</italic><sup>−/−</sup> males (n=24 and 31, respectively) to initiate each mating act toward the stimulus female. (<bold>G</bold>) Number of each mating act performed. (<bold>H</bold>) Setup for testing the mating behavior of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males using an <italic>esr2b</italic>-deficient female as the stimulus. (<bold>I</bold>) Latency of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males (Δ8 line; n=23 and 22, respectively) to initiate each mating act toward the stimulus female. (<bold>J</bold>) Number of each mating act performed. (<bold>K, L</bold>) Total number of each aggressive act observed among <italic>esr1</italic><sup>+/+</sup> or <italic>esr1</italic><sup>−/−</sup> males (n=6 per genotype) (<bold>K</bold>) and among <italic>esr2a</italic><sup>+/+</sup> or <italic>esr2a</italic><sup>−/−</sup> males (Δ8 line; n=8 and 7, respectively) (<bold>L</bold>) in the tank. Scale bars represent 50 μm. For abbreviations of brain nuclei, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1.</xref> Statistical differences were assessed by unpaired <italic>t</italic> test, with Welch’s correction where appropriate (<bold>A, C, G, J, K, L</bold>) and Gehan-Breslow-Wilcoxon test (<bold>F, I</bold>). Error bars represent SEM. *p&lt;0.05, **p&lt;0.01.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Generation of <italic>esr2a</italic>-deficient medaka.</title><p>(<bold>A</bold>) Schematic of the <italic>esr2a</italic> locus showing the location of the CRISPR (clustered regularly interspaced short palindromic repeats) target site. Each exon is numbered. Nucleotide sequences of the wild-type (<italic>esr2a</italic><sup>+</sup>) and mutant (<italic>esr2a</italic><sup>−</sup> [Δ8] and <italic>esr2a</italic><sup>−</sup> [Δ4]) alleles at the target site are shown, with the CRISPR RNA target sequence underlined. Dashes indicate deleted nucleotides. (<bold>B</bold>) Comparison of the amino acid sequences deduced from the <italic>esr2a</italic><sup>+</sup> and <italic>esr2a</italic><sup>−</sup> (Δ8 and Δ4) alleles. Amino acid numbers are shown on the right. The DNA-binding domain (residues 161–234 of wild-type Esr2a) and ligand-binding domain (304–514) are shaded in gray. The sequences altered by the frameshift are indicated in red. Asterisks denote stop codons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Expression of <italic>ara</italic> and <italic>arb</italic> in the brain of males deficient for each ESR.</title><p>(<bold>A</bold>) Total area of <italic>ara</italic> expression signal in each brain nucleus of <italic>esr1</italic><sup>+/+</sup> and <italic>esr1</italic><sup>−/−</sup> males (n=5 per genotype). (<bold>B</bold>) Representative images showing the coexpression of <italic>arb</italic> and <italic>esr1</italic> in the PMp and aPPp. Left panels show <italic>arb</italic> expression (magenta), middle panels show <italic>esr1</italic> expression (green), and right panels show the merged images with DAPI staining (blue). White arrowheads indicate neurons coexpressing <italic>arb</italic> and <italic>esr1</italic>. (<bold>C</bold>) Total area of <italic>arb</italic> expression signal in each brain nucleus of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males (Δ8 line; n=4 and 5, respectively, except for NPT of <italic>esr2a</italic><sup>+/+</sup> males, where n=5). (<bold>D</bold>) Representative images showing the coexpression of <italic>ara</italic> and <italic>esr2a</italic> in the PPa, pPPp, and NVT. Left panels show <italic>ara</italic> expression (magenta), middle panels show <italic>esr2a</italic> expression (green), and right panels show the merged images with DAPI staining (blue). White arrowheads indicate neurons coexpressing <italic>ara</italic> and <italic>esr2a</italic>. (<bold>E</bold>) Total area of <italic>ara</italic> expression signal in each brain nucleus of <italic>esr2b</italic><sup>+/+</sup> and <italic>esr2b</italic><sup>−/−</sup> males (n=5 per genotype). (<bold>F</bold>) Representative images of <italic>ara</italic> expression in the NAT. (<bold>G</bold>) Total area of <italic>arb</italic> expression signal in each brain nucleus of <italic>esr2b</italic><sup>+/+</sup> and <italic>esr2b</italic><sup>−/−</sup> males (n=5 per genotype except for Vv of <italic>esr2b</italic><sup>+/+</sup> males, where n=4). (<bold>H</bold>) Representative images of <italic>arb</italic> expression in the PPa. Each quantitative dataset is displayed in two graphs for visual clarity. Scale bars represent 20 μm (<bold>B, D</bold>) and 50 μm (<bold>F, H</bold>). For abbreviations of brain nuclei, see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1.</xref> Statistical differences were assessed by unpaired <italic>t</italic> test, with Welch’s correction where appropriate (<bold>A, C, E, G</bold>). Error bars represent SEM. *p&lt;0.05.</p><p><supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig5-figsupp2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Mating behavior of <italic>esr1</italic>-deficient males.</title><p>Latency of <italic>esr1</italic><sup>+/+</sup> and <italic>esr1</italic><sup>−/−</sup> males (n=23 and 24, respectively) to initiate each mating act toward the stimulus wild-type female. Statistical differences were assessed by Gehan-Breslow-Wilcoxon test. **p&lt;0.01.</p><p><supplementary-material id="fig5s3sdata1"><label>Figure 5—figure supplement 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig5-figsupp3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig5-figsupp3-v1.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>Mating and aggressive behaviors of <italic>esr2a</italic>-deficient males.</title><p>(<bold>A</bold>) Latency of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males (Δ8 line; n=24 and 23, respectively) to initiate each mating act toward the stimulus wild-type female. (<bold>B</bold>) Latency of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males (Δ4 line; n=23 per genotype) to initiate each mating act toward the stimulus wild-type female. (<bold>C</bold>) Latency of <italic>esr2a</italic><sup>+/+</sup> and <italic>esr2a</italic><sup>−/−</sup> males (Δ4 line; n=24 per genotype) to initiate each mating act toward the stimulus <italic>esr2b</italic>-deficient female. (<bold>D</bold>) Number of each mating act performed. (<bold>E</bold>) Total number of each aggressive act observed among <italic>esr2a</italic><sup>+/+</sup> or <italic>esr2a</italic><sup>−/−</sup> males (Δ4 line; n=8 and 7, respectively) in the tank. Statistical differences were assessed by Gehan-Breslow-Wilcoxon test (<bold>A, B, C</bold>) and unpaired <italic>t</italic> test, with Welch’s correction where appropriate (<bold>D, E</bold>). Error bars represent SEM. *p&lt;0.05.</p><p><supplementary-material id="fig5s4sdata1"><label>Figure 5—figure supplement 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-97106-fig5-figsupp4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-97106-fig5-figsupp4-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title><italic>esr1</italic>- and <italic>esr2a</italic>-deficient males are, respectively, less motivated to mate and less aggressive</title><p>If Esr1 and Esr2a truly mediate the behavioral effects of brain-derived estrogens through the activation of AR expression, then <italic>esr1</italic>- and <italic>esr2a</italic>-deficient males should exhibit impaired male-typical behaviors. More specifically, given that Esr1 and Esr2a function to activate the expression of <italic>arb</italic> and <italic>ara</italic>, which are responsible for male mating and aggression, respectively (<xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>), <italic>esr1</italic>- and <italic>esr2a</italic>-deficient males should be less motivated to mate and less aggressive, respectively.</p><p>To test these ideas, we first evaluated the mating behavior of <italic>esr1</italic>-deficient males using a wild-type female as the stimulus. As expected, <italic>esr1</italic><sup>−/−</sup> males showed a significantly longer latency to initiate following than <italic>esr1</italic><sup>+/+</sup> males (p=0.0055) (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>), suggesting that they are less motivated to mate. This was further confirmed in tests using an <italic>esr2b</italic>-deficient female as the stimulus, where <italic>esr1</italic><sup>−/−</sup> males showed a longer latency to following and fewer courtship displays than <italic>esr1</italic><sup>+/+</sup> males (p=0.0426 and 0.0039, respectively) (<xref ref-type="fig" rid="fig5">Figure 5E–G</xref>). In contrast, no deficits were observed in the mating behavior of <italic>esr2a</italic><sup>−/−</sup> males toward wild-type females (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A and B</xref>). Although <italic>esr2a</italic><sup>−/−</sup> males of the Δ8 line showed a shorter latency to following than their wild-type siblings in tests using a stimulus <italic>esr2b</italic>-deficient female (p=0.0146) (<xref ref-type="fig" rid="fig5">Figure 5H–J</xref>), this was not reproduced in the Δ4 line (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4C and D</xref>). We subsequently assessed aggressive behavior and found no defects in <italic>esr1</italic><sup>−/−</sup> males (<xref ref-type="fig" rid="fig5">Figure 5K</xref>). Conversely, <italic>esr2a</italic><sup>−/−</sup> males from both the Δ8 and Δ4 lines exhibited significantly fewer fin displays than their wild-type siblings (p=0.0461 and 0.0293, respectively). Circles followed a similar pattern, with a significant reduction in the Δ8 line (p=0.0446) and a comparable but nonsignificant decrease in the Δ4 line (p=0.1512) (<xref ref-type="fig" rid="fig5">Figure 5L</xref>, <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3E</xref>), showing less aggression. Taken together with the previous finding that <italic>esr2b</italic>-deficient males show no deficits in either mating or aggressive behavior (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>), these results suggest that brain-derived estrogens can promote mating with females by stimulating <italic>arb</italic> expression through Esr1 and can increase aggression toward other males by stimulating <italic>ara</italic> expression through Esr2a. Nonetheless, behavioral deficits in <italic>esr1</italic>- and <italic>esr2a</italic>-deficient males were relatively mild as compared with <italic>cyp19a1b</italic>-deficient males (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and <italic>ara</italic>- and <italic>arb</italic>-deficient males (<xref ref-type="bibr" rid="bib38">Nishiike and Okubo, 2024</xref>), suggesting that a compensatory mechanism may exist between ESR subtypes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we found that male medaka deficient for <italic>cyp19a1b</italic> exhibit severely impaired male-typical mating and aggression. This observation was noteworthy because the fish had markedly elevated brain levels of 11KT, the primary driver of male-typical behaviors in teleosts (<xref ref-type="bibr" rid="bib43">Okubo et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Kawabata-Sakata et al., 2024</xref>). Deficits in mating were rescued by estrogen administration, indicating that reduced brain estrogen levels are the primary cause of the observed mating impairment; in other words, brain-derived estrogens are pivotal at least for male-typical mating behaviors in teleosts. This was also notable because, unlike in rodents, where brain-derived estrogens play essential roles in the establishment and activation of male-typical behaviors as posited by the ‘aromatization hypothesis’, these estrogens have been regarded as dispensable for male behaviors in many vertebrates, including teleosts (<xref ref-type="bibr" rid="bib48">Thornton et al., 2009</xref>; <xref ref-type="bibr" rid="bib4">Bakker, 2022</xref>; <xref ref-type="bibr" rid="bib43">Okubo et al., 2022</xref>). In addition, the rescue of behavioral phenotypes by estrogen administration in adults suggests that in teleosts, unlike in rodents, brain-derived estrogens early in life are not essential for the execution of male-typical behaviors. While brain-derived estrogens are necessary for male behaviors in both rodents and teleosts, the life stages at which they exert their behavioral effects probably differ between these species. Brain aromatase activity in teleosts increases with age and, at adulthood, reaches 100–1000 times that in rodents (<xref ref-type="bibr" rid="bib10">Diotel et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">Okubo et al., 2022</xref>). In contrast, brain aromatase activity in rodents reaches its peak during the perinatal period and thereafter declines with age (<xref ref-type="bibr" rid="bib29">Lephart, 1996</xref>), although it remains important for male behavior in adulthood. This variation among species may represent the activation of brain estrogen synthesis at life stages critical for sexual differentiation of behavior that is unique to each species.</p><p>Brain-derived estrogens serve several functions during the process of sexual differentiation of the mouse brain, including the synthesis of prostaglandin PGE2 and the activation of synaptic and neurodevelopmental genes; however, the specific mechanism whereby these estrogens affect male behaviors remains obscure (<xref ref-type="bibr" rid="bib33">McCarthy et al., 2017</xref>; <xref ref-type="bibr" rid="bib13">Gegenhuber et al., 2022</xref>; <xref ref-type="bibr" rid="bib34">McCarthy, 2023</xref>). Our findings in medaka indicate that brain-derived estrogens facilitate male-typical behaviors by potentiating androgen/AR signaling in behaviorally relevant brain regions via the direct stimulation of AR transcription. More specifically, they indicate that brain-derived estrogens (1) promote mating by stimulating the transcription of <italic>arb</italic> in some preoptic and hypothalamus nuclei via Esr1, and (2) increase aggression by stimulating the transcription of <italic>ara</italic> in other preoptic and hypothalamus nuclei through Esr2a. This model of the mechanism underlying the action of brain-derived estrogens would explain the apparent contradiction that, in teleosts, androgens per se elicit male behaviors without aromatization, while estrogen synthesis in the brain is also critical for these behaviors. Our data also indicate that the two AR genes, <italic>ara</italic> and <italic>arb</italic>, are direct downstream targets of brain-derived estrogens that mediate male behaviors, only a few of which have been identified thus far. In mice, perinatal brain estrogens increase <italic>Ar</italic> expression in the bed nucleus of the stria terminalis and preoptic area, two brain regions that have been implicated in male behaviors (<xref ref-type="bibr" rid="bib20">Juntti et al., 2010</xref>). Recent evidence suggests that ESR1 binds to the regulatory genomic region of <italic>Ar</italic> in these brain regions in mice (<xref ref-type="bibr" rid="bib13">Gegenhuber et al., 2022</xref>). Given these facts, the idea that brain-derived estrogens enhance androgen/AR signaling by directly stimulating AR transcription may apply to a wide range of species, including rodents.</p><p>Consistent with our results, studies in several teleost species have shown that treatment of males with an aromatase inhibitor reduces their male-typical behaviors, while estrogens exert the opposite effect (<xref ref-type="bibr" rid="bib14">Hallgren et al., 2006</xref>; <xref ref-type="bibr" rid="bib39">O’Connell and Hofmann, 2012</xref>; <xref ref-type="bibr" rid="bib17">Huffman et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Jalabert et al., 2015</xref>). Conversely, it has been shown in various teleosts, including medaka, that treatment with exogenous estrogens attenuates male behaviors (<xref ref-type="bibr" rid="bib6">Bayley et al., 1999</xref>; <xref ref-type="bibr" rid="bib7">Bell, 2001</xref>; <xref ref-type="bibr" rid="bib8">Bjerselius et al., 2001</xref>; <xref ref-type="bibr" rid="bib44">Oshima et al., 2003</xref>; <xref ref-type="bibr" rid="bib32">Martinović et al., 2007</xref>). A possible explanation for this discrepancy is that estrogens may either stimulate or suppress male-typical behaviors, depending on their concentration. All studies showing the suppressive effects of exogenous estrogens were conducted at doses higher than those used in the present study or at doses mimicking the levels typical of adult females (<xref ref-type="bibr" rid="bib25">Kayo et al., 2020</xref>). In addition, our previous study in male medaka showed that high doses of exogenous estrogens induce the expression of <italic>esr2b</italic>, which prevents male-typical mating behavior, in behaviorally relevant brain regions (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>). Thus, the development of male behaviors may require moderate brain estrogen levels that are sufficient to induce the expression of <italic>ara</italic> and <italic>arb</italic>, but not <italic>esr2b</italic>, in the underlying neural circuitry. Considering this, the lack of aggression recovery in E2-treated <italic>cyp19a1b</italic>-deficient males in this study may be explained by the possibility that the E2 dose used was sufficient to induce not only <italic>ara</italic> and <italic>arb</italic> but also <italic>esr2b</italic> expression in aggression-relevant circuits, which potentially suppressed aggression. Another possibility that is not mutually exclusive is that endogenous levels of brain estrogens are sufficient to motivate males to engage in male-typical behaviors, and therefore exogenous estrogens have no further effect. This possibility is at least likely for mating behavior, as estrogen treatment facilitated mating behavior in <italic>cyp19a1b</italic>-deficient males but not in their wild-type siblings. Further studies using <italic>cyp19a1b</italic> mutants from different teleost species are needed to explore these possibilities and to determine whether the findings in medaka hold for other teleosts.</p><p>In summary, we have shown that brain-derived estrogens promote male-typical behaviors by increasing brain sensitivity to testicular androgens through the stimulation of AR expression. Our findings challenge the prevailing view that brain-derived estrogens have little effect on male-typical behaviors in species where testicular androgens elicit these behaviors directly without aromatization to estrogens in the brain and unveil a previously unappreciated mechanism of the action of brain-derived estrogens. Because teleosts account for the majority of vertebrates, with rodents and some birds being the only known exceptions, the mechanism of their action that we have identified in medaka may be evolutionarily ancient and widely conserved across species.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Gene (<italic>Oryzias latipes</italic>)</td><td align="left" valign="top"><italic>cyp19a1b</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:AB591736</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr1</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:XM_020714493</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr2a</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:NM_001104702</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr2b</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:XM_020713365</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>ara</italic></td><td align="left" valign="top">GenBank; NBRP Medaka</td><td align="left" valign="top">GenBank:NM_001122911; NBRP Medaka clone ID:olova36n18</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>arb</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:NM_001104681</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>vt</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:NM_001278891</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>gal</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:LC532140</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Gene (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>actb</italic></td><td align="left" valign="top">GenBank</td><td align="left" valign="top">GenBank:NM_001104808</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Strain, strain background (<italic>O. latipes</italic>)</td><td align="left" valign="top">d-rR</td><td align="left" valign="top">NBRP Medaka</td><td align="left" valign="top">Strain ID:MT837</td><td align="left" valign="top">Maintained in a closed colony over 15 years in Okubo lab</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>cyp19a1b</italic>-deficient line</td><td align="left" valign="top">This paper</td><td align="left" valign="top">TILLING ID:57D05</td><td align="left" valign="top">Generated and maintained in Okubo lab</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr1</italic>-deficient line</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/pnasnexus/pgad413">https://doi.org/10.1093/pnasnexus/pgad413</ext-link></td><td align="left" valign="top">N/A</td><td align="left" valign="top">Generated and maintained in Okubo lab</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr2a</italic>-deficient Δ8 line</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">Generated and maintained in Okubo lab</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr2a</italic>-deficient Δ4 line</td><td align="left" valign="top">This paper</td><td align="left" valign="top">N/A</td><td align="left" valign="top">Generated and maintained in Okubo lab</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>O. latipes</italic>)</td><td align="left" valign="top"><italic>esr2b</italic>-deficient line</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cub.2021.01.089">https://doi.org/10.1016/j.cub.2021.01.089</ext-link></td><td align="left" valign="top">TILLING ID:46E12</td><td align="left" valign="top">Generated and maintained in Okubo lab</td></tr><tr><td align="left" valign="top">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="top">HEK293T</td><td align="left" valign="top">Riken BRC Cell Bank</td><td align="left" valign="top">cell number:RCB2202; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:CVCL_0063">CVCL_0063</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Cell line (<italic>H. sapiens</italic>)</td><td align="left" valign="top">HeLa</td><td align="left" valign="top">Riken BRC Cell Bank</td><td align="left" valign="top">cell number:RCB0007; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:CVCL_0030">CVCL_0030</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Alkaline phosphatase-conjugated anti-DIG antibody (sheep polyclonal)</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:11093274910; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_514497">AB_514497</ext-link></td><td align="left" valign="top">(1:500 or 1:2000)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-DIG antibody (mouse monoclonal)</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">cat#:ab420; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_304362">AB_304362</ext-link></td><td align="left" valign="top">(1:200)</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Horseradish peroxidase-conjugated anti-fluorescein antibody (sheep polyclonal)</td><td align="left" valign="top">PerkinElmer</td><td align="left" valign="top">cat#:NEF710001EA; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2737388">AB_2737388</ext-link></td><td align="left" valign="top">(1:1000)</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pcDNA3.1/V5-His-TOPO</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">cat#:K480001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pGL4.10</td><td align="left" valign="top">Promega</td><td align="left" valign="top">cat#:E6651</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pGL4.74</td><td align="left" valign="top">Promega</td><td align="left" valign="top">cat#:E6921</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">Medaka bacterial artificial chromosome (BAC) clone containing the <italic>ara</italic> locus</td><td align="left" valign="top">NBRP Medaka</td><td align="left" valign="top">NBRP Medaka clone ID:ola1-111G01</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">Medaka BAC clone containing the <italic>arb</italic> locus</td><td align="left" valign="top">NBRP Medaka</td><td align="left" valign="top">NBRP Medaka clone ID:ola1-192H15</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">CRISPR RNA (crRNA) for medaka <italic>esr2a</italic></td><td align="left" valign="top">Fasmac</td><td align="left" valign="top">N/A</td><td align="left" valign="top"><named-content content-type="sequence">CTACGGCGTGTGGTCATGCGAGG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">Trans-activating CRISPR RNA (tracrRNA)</td><td align="left" valign="top">Fasmac</td><td align="left" valign="top">cat#:GE-002</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Cas9</td><td align="left" valign="top">Nippon Gene</td><td align="left" valign="top">cat#:316-08651</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Estradiol ELISA Kit</td><td align="left" valign="top">Cayman Chemical Company</td><td align="left" valign="top">cat#:582251</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Testosterone ELISA Kit</td><td align="left" valign="top">Cayman Chemical Company</td><td align="left" valign="top">cat#:582701</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">11-Keto Testosterone ELISA Kit</td><td align="left" valign="top">Cayman Chemical Company</td><td align="left" valign="top">cat#:582751</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">RNeasy Plus Universal Mini Kit</td><td align="left" valign="top">QIAGEN</td><td align="left" valign="top">cat#:73404</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">SuperScript VILO cDNA Synthesis Kit</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">cat#:11754050</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">LightCycler 480 SYBR Green I Master</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:04707516001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">DIG RNA Labeling Mix</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:11277073910</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Fluorescein RNA Labeling Mix</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:11685619910</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">T7 RNA polymerase</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:10881775001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">SP6 RNA polymerase</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:10810274001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Dual-Luciferase Reporter Assay System</td><td align="left" valign="top">Promega</td><td align="left" valign="top">cat#:E1910</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">PrimeSTAR Mutagenesis Basal Kit</td><td align="left" valign="top">Takara Bio</td><td align="left" valign="top">cat#:R046A</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Alexa Fluor 555 Tyramide SuperBoost Kit, goat anti-mouse IgG</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">cat#:B40913</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">TSA Plus Fluorescein System</td><td align="left" valign="top">PerkinElmer</td><td align="left" valign="top">cat#:NEL741001KT</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Sep-Pak C18 Plus Light Cartridge</td><td align="left" valign="top">Waters Corporation</td><td align="left" valign="top">cat#:WAT023501</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Estradiol-17β (E2)</td><td align="left" valign="top">Fujifilm Wako Pure Chemical</td><td align="left" valign="top">cat#:058-04043</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">5-Bromo-4-chloro-3-indolyl phosphate</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:11383221001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Nitro blue tetrazolium</td><td align="left" valign="top">Roche Diagnostics</td><td align="left" valign="top">cat#:11383213001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Lipofectamine LTX</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">cat#:15338100</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Charcoal/dextran-stripped fetal bovine serum</td><td align="left" valign="top">Cytiva</td><td align="left" valign="top">cat#:SH30068</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">AlphaFold 3</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://alphafoldserver.com/about">https://alphafoldserver.com/about</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_025885">SCR_025885</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">PyMOL</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.pymol.org">https://www.pymol.org</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_000305">SCR_000305</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Olyvia</td><td align="left" valign="top">Olympus</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_016167">SCR_016167</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Jaspar</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="http://jaspar.genereg.net/">http://jaspar.genereg.net/</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_003030">SCR_003030</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">Match</td><td align="left" valign="top"><ext-link ext-link-type="uri" xlink:href="http://gene-regulation.com/pub/programs.html">http://gene-regulation.com/pub/programs.html</ext-link></td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_007787">SCR_007787</ext-link></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">GraphPad Prism</td><td align="left" valign="top">GraphPad Software</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals and cell lines</title><p>Wild-type d-rR strain medaka and mutant medaka deficient for <italic>cyp19a1b</italic> and <italic>esr2a</italic> (generated in this study), <italic>esr1</italic> (<xref ref-type="bibr" rid="bib11">Fleming et al., 2023</xref>), and <italic>esr2b</italic> (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>) were maintained in a recirculating system at 28°C on a 14/10 hr light/dark cycle. Three or four times a day, they were fed live brine shrimp and dry food (Otohime; Marubeni Nisshin Feed, Tokyo, Japan). Sexually mature adults (2–6 months) were used for experiments and assigned randomly to experimental groups. Tissues were consistently sampled 1–5 hr after lights on. In each experiment, siblings raised under the same conditions were used as the comparison group to control for the effects of genetic diversity and environmental variation.</p><p>HEK293T and HeLa cells used in this study were confirmed to be mycoplasma-free (Biotherapy Institute of Japan, Tokyo, Japan) and authenticated by short tandem repeat profiling (National Institute of Biomedical Innovation, Osaka, Japan).</p></sec><sec id="s4-2"><title>Generation of mutant medaka</title><p><italic>cyp19a1b</italic>-deficient medaka were generated essentially as previously described (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>). In brief, a TILLING library of 5760 chemically mutagenized medaka (<xref ref-type="bibr" rid="bib46">Taniguchi et al., 2006</xref>) was screened for mutations in exons 3, 4, and 5 of <italic>cyp19a1b</italic> by direct sequencing of PCR-amplified fragments. A founder (ID: 57D05) with a nonsense mutation in exon 4 (K105*) was identified (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>) and backcrossed to the wild-type d-rR strain for more than six generations to eliminate background mutations. Heterozygous males and females were intercrossed to generate wild-type, heterozygous, and homozygous siblings. All experimental fish were subjected to genotyping by PCR amplification across the mutation, followed by high-resolution melting (HRM) analysis, using the primers and probe listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. HRM analysis was performed on the LightCycler 480 System II (Roche Diagnostics, Basel, Switzerland) using the LCGreen Plus dye (BioFire Defense, Salt Lake City, UT, USA).</p><p><italic>esr2a</italic>-deficient medaka were generated by using the CRISPR/Cas9 system. A CRISPR RNA (crRNA) targeting exon 3 of <italic>esr2a</italic> (Fasmac, Kanagawa, Japan) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>) was injected with trans-activating crRNA (Fasmac) and Cas9 protein (Nippon Gene Co. Ltd., Tokyo, Japan) into the cytoplasm of one- or two-cell stage embryos. The resulting fish were screened for germline mutations by outcrossing to wild-type fish and testing progeny for target site mutations by T7 endonuclease I assay (<xref ref-type="bibr" rid="bib26">Kim et al., 2009</xref>) and direct sequencing. Two founders were identified that reproducibly yielded progeny carrying frameshift mutations that eliminated the DNA- and ligand-binding domains of Esr2a: one yielded progeny carrying an 8 bp deletion (Δ8); the other yielded progeny carrying a 4 bp deletion (Δ4) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). The DNA- and ligand-binding domains of medaka Esr2a were identified by sequence alignment with yellow perch (<italic>Perca flavescens</italic>) Esr2a, for which these domain locations have been reported (<xref ref-type="bibr" rid="bib31">Lynn et al., 2008</xref>). The progeny were intercrossed to obtain wild-type, heterozygous, and homozygous siblings. The genotype of each experimental fish was determined by HRM analysis as described above.</p><p>A previous study reported that <italic>esr2a</italic>-deficient female medaka cannot release eggs due to oviduct atresia (<xref ref-type="bibr" rid="bib24">Kayo et al., 2019</xref>). Likewise, some <italic>esr2a</italic>-deficient females generated in this study, despite the limited sample size, exhibited spawning behavior but were unable to release eggs (Δ8 line: 2/3; Δ4 line: 1/1), while such failure was not observed in wild-type females (Δ8 line: 0/12; Δ4 line: 0/11). These results support the effective loss of <italic>esr2a</italic> function.</p></sec><sec id="s4-3"><title>Measurement of sex steroid levels</title><p>Brain and peripheral levels of sex steroids were determined by enzyme-linked immunosorbent assay (ELISA) (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>). Total lipids were extracted from the brain and from peripheral tissues, specifically the caudal half of the body excluding the head and visceral organs, of <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males with chloroform/methanol (2:1, vol/vol) and purified on a Sep-Pak C18 Plus Light Cartridge (Waters Corporation, Milford, MA, USA). Tissue levels of E2, testosterone, and 11KT were measured by using Estradiol, Testosterone, and 11-Keto Testosterone ELISA kits, respectively (Cayman Chemical Company, Ann Arbor, MI, USA).</p></sec><sec id="s4-4"><title>Real-time PCR</title><p>Total RNA was isolated from the brains of <italic>cyp19a1b</italic><sup>+/+</sup>, <italic>cyp19a1b</italic><sup>+/−</sup>, and <italic>cyp19a1b</italic><sup>−/−</sup> males using the RNeasy Plus Universal Mini Kit (QIAGEN, Hilden, Germany). cDNA was synthesized with the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, MA, USA). Real-time PCR was performed on the LightCycler 480 System II using the LightCycler 480 SYBR Green I Master (Roche Diagnostics). Melting curve analysis was conducted to verify that a single amplicon was obtained in each sample. The β-actin gene (<italic>actb</italic>; GenBank accession number NM_001104808) was used to normalize the levels of target transcripts. The primers used for real-time PCR are shown in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-5"><title>Protein structure prediction</title><p>Structural predictions of Cyp19a1b proteins were conducted using AlphaFold 3 (<xref ref-type="bibr" rid="bib1">Abramson et al., 2024</xref>). Amino acid sequences corresponding to the wild-type allele and the mutant allele generated in this study were submitted to the AlphaFold 3 prediction server. The resulting models were visualized with PyMOL (Schrödinger, New York, NY, USA), and key structural features, including the membrane helix, aromatic region, and heme-binding loop, were annotated.</p></sec><sec id="s4-6"><title>Mating behavior test</title><p>Mating behavior was tested essentially as previously described (<xref ref-type="bibr" rid="bib16">Hiraki-Kajiyama et al., 2019</xref>). In brief, on the day before behavioral testing, each focal male (<italic>cyp19a1b</italic>-, <italic>esr1</italic>-, and <italic>esr2a</italic>-deficient lines) was placed with a stimulus female (wild-type females in the tests shown in <xref ref-type="fig" rid="fig1">Figure 1D and E</xref>, <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>, and <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A and B</xref>; <italic>esr2b</italic>-deficient females in <xref ref-type="fig" rid="fig1">Figures 1F–I</xref>–<xref ref-type="fig" rid="fig2">2A–E</xref>, <xref ref-type="fig" rid="fig5">5E–J</xref> and <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4C and D</xref>) in a 2 l rectangular tank with a perforated transparent partition separating them. The setup was modified for E2-treated males, which were kept on E2 treatment and not introduced to the test tanks until the day of testing to ensure the efficacy of E2 treatment. The partition was removed 1 hr after lights on, and fish were allowed to interact for 30 min while their behavior was recorded with a digital video camera (HC-V360MS, HC-VX985M, or HC-W870M; Panasonic Corporation, Osaka, Japan). The first 15 min of the recording was used to calculate the latency to the first following, courtship display, wrapping, and spawning. In tests using an <italic>esr2b</italic>-deficient female as the stimulus fish, the latency to spawn could not be calculated because the female was unreceptive to males and did not spawn. Therefore, the sexual motivation of the focal male was assessed by counting the number of courtship displays and wrapping attempts in 30 min. To evaluate courtship displays performed by stimulus <italic>esr2b</italic>-deficient females toward focal males, the recording period was extended to 2 hr, as these females take longer to initiate courtship (<xref ref-type="bibr" rid="bib37">Nishiike et al., 2021</xref>). In all video analyses, the researcher was blind to the fish genotype and treatment.</p></sec><sec id="s4-7"><title>Aggressive behavior test</title><p>To test male-male aggressive behavior (<xref ref-type="bibr" rid="bib51">Yamashita et al., 2020</xref>), four males of the same genotype (<italic>cyp19a1b</italic>-, <italic>esr1</italic>-, and <italic>esr2a</italic>-deficient lines) that were unfamiliar with one another were placed together in a test tank 1 hr after lights on. After 1 min of acclimation to the tank, fish were allowed to interact for 15 min while their behavior was video-recorded as described above. The total number of each aggressive act (chase, fin display, circle, strike, and bite) displayed by the four males in the tank was counted manually from the video recordings.</p></sec><sec id="s4-8"><title>E2 treatment</title><p><italic>cyp19a1b</italic><sup>+/+</sup> and <italic>cyp19a1b</italic><sup>−/−</sup> males were treated with 1 ng/ml of E2 (Fujifilm Wako Pure Chemical, Osaka, Japan), which was first dissolved in 100% ethanol (vehicle), or with the vehicle alone by immersion in water for 4 days, with daily water changes to maintain the nominal concentration. The mating and aggressive behaviors of males before and after E2 treatment were evaluated as described above. The expression of <italic>ara</italic> and <italic>arb</italic> in the brain of E2- and vehicle-treated males was investigated by single-label in situ hybridization as described below. Although the exact increase in brain E2 levels following E2 treatment was not quantified, the observed positive effects on behavior and gene expression suggest that it was sufficient.</p></sec><sec id="s4-9"><title>Single-label in situ hybridization</title><p>Digoxigenin (DIG)-labeled cRNA probes were generated by in vitro transcription using DIG RNA Labeling Mix (Roche Diagnostics), T7 RNA polymerase (Roche Diagnostics), and the following cDNA fragments: <italic>ara</italic>, nucleotide 16–1030 of GenBank NM_001122911 (1015 bp); <italic>arb</italic>, 53–1233 of NM_001104681 (1181 bp); <italic>vt</italic>, 1–845 of NM_001278891 (845 bp); and <italic>gal</italic>, 5–533 of LC532140 (529 bp).</p><p>Single-label in situ hybridization was essentially done as described (<xref ref-type="bibr" rid="bib22">Kawabata-Sakata et al., 2020</xref>). In brief, male brains from the <italic>cyp19a1b</italic>-deficient line (analysis of <italic>ara</italic>, <italic>arb</italic>, <italic>vt</italic>, and <italic>gal</italic>) and from the <italic>esr1</italic>-, <italic>esr2a</italic>-, and <italic>esr2b</italic>-deficient lines (analysis of <italic>ara</italic> and <italic>arb</italic>) were fixed in 4% paraformaldehyde and embedded in paraffin. Serial coronal sections of 10 μm thickness were hybridized with a DIG-labeled probe. Hybridization signal was detected with anti-DIG conjugated to alkaline phosphatase (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_514497">AB_514497</ext-link>; Roche Diagnostics) and visualized using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium substrate (Roche Diagnostics). After color development for 15 min (<italic>gal</italic>), 2 hr (<italic>vt</italic>), or overnight (<italic>ara</italic> and <italic>arb</italic>), sections were imaged using a VS120 virtual slide microscope (Olympus, Tokyo, Japan). The total area of signal across all relevant sections, including both hemispheres, was calculated for each brain nucleus using Olyvia software (Olympus). Images were converted to a 256-level intensity scale, and pixels with intensities from 161 to 256 were considered signals. All sections used for comparison were processed in the same batch, without corrections between samples. Medaka brain atlases (<xref ref-type="bibr" rid="bib3">Anken and Bourrat, 1998</xref>; <xref ref-type="bibr" rid="bib18">Ishikawa et al., 1999</xref>) were used to identify brain nuclei.</p></sec><sec id="s4-10"><title>Transcriptional activity assay</title><p>Each full-length coding region of medaka Esr1 (GenBank XM_020714493), Esr2a (NM_001104702), and Esr2b (XM_020713365) cDNA was amplified by PCR and inserted into the expression vector pcDNA3.1/V5-His-TOPO (Thermo Fisher Scientific). Each nucleotide sequence of the 5′-flanking region of <italic>ara</italic> and <italic>arb</italic> was retrieved from the Ensembl medaka genome assembly and analyzed for potential canonical ERE-like sequences using Jaspar (version 5.0_alpha) and Match (public version 1.0) with default settings. No ERE-like sequence was detected in <italic>ara</italic>; therefore, the gene body and 3′-flanking region were also analyzed in this case. The transcription initiation site for <italic>ara</italic> and <italic>arb</italic> was determined based on an expressed sequence tag clone deposited in National BioResource Project (NBRP) Medaka (olova36n18) and GenBank NM_001104681, respectively. Medaka bacterial artificial chromosome (BAC) clones containing the <italic>ara</italic> (clone ID: ola1-111G01) and <italic>arb</italic> (ola1-192H15) loci were obtained from NBRP Medaka. A 4530 bp genomic DNA fragment upstream of <italic>ara</italic> exon 3 (comprising 2330 bp of the 5′-flanking region, exon 1, intron 1, exon 2, intron 2, and the first 32 bp of exon 3) was amplified by PCR from the BAC clone, fused to a P2A self-cleaving peptide sequence (<xref ref-type="bibr" rid="bib27">Kim et al., 2011</xref>) at the 3′ end, and inserted into the NheI site of the luciferase reporter vector pGL4.10 (Promega, Madison, WI, USA). Similarly, a 3995 bp fragment upstream of the first methionine codon of <italic>arb</italic> (comprising 3815 bp of the 5′-flanking region and 180 bp of exon 1) was PCR-amplified and inserted into pGL4.10. The resulting constructs were transiently transfected into HEK293T (<italic>ara</italic>) or HeLa (<italic>arb</italic>) cells, together with an internal control vector pGL4.74 (Promega) and the Esr1, Esr2a, or Esr2b expression construct using Lipofectamine LTX (Thermo Fisher Scientific). Six hours after transfection, cells were incubated for 18 hr without and with E2 at doses of 10<sup>–11</sup> M, 10<sup>–9</sup> M, and 10<sup>–7</sup> M in Dulbecco’s modified Eagle’s medium (phenol red-free) containing 5% charcoal/dextran-stripped fetal bovine serum (Cytiva, Marlborough, MA, USA). Luciferase activity was determined using the Dual-Luciferase Reporter Assay System (Promega) on the GloMax 20/20n Luminometer (Promega). All assays were conducted in duplicate or triplicate and repeated independently three times.</p><p>Further assays were performed with luciferase reporter constructs carrying point mutations in the ERE-like sequences to identify the ERE responsible for E2 induction of <italic>ara</italic> and <italic>arb</italic> transcription. Each half-site of the responsible ERE-like sequence was mutated into a HindIII recognition site using the PrimeSTAR Mutagenesis Basal Kit (Takara Bio, Shiga, Japan). Transcriptional activity assays with these constructs were done as described above, except that a single dose of E2 (10<sup>–7</sup> M) was used.</p></sec><sec id="s4-11"><title>Double-label in situ hybridization</title><p>DIG-labeled cRNA probes for <italic>ara</italic> and <italic>arb</italic> were prepared as described above. Fluorescein-labeled cRNA probes for <italic>esr1</italic> and <italic>esr2a</italic> were generated by in vitro transcription using Fluorescein RNA Labeling Mix (Roche Diagnostics), SP6 or T7 RNA polymerase (Roche Diagnostics), and the following cDNA fragments: <italic>esr1</italic>, nucleotides 1694–2781 of XM_020714493 (1088 bp); <italic>esr2a</italic>, 1838–2276 of NM_001104702 plus 763 bp of 3′-untranslated sequence derived from the Ensembl medaka genome assembly (439 bp).</p><p>Double-label in situ hybridization was done as described previously (<xref ref-type="bibr" rid="bib11">Fleming et al., 2023</xref>), with minor modifications. In brief, brains dissected from wild-type males were fixed in 4% paraformaldehyde, embedded in paraffin, and coronally sectioned at 10 μm thickness. Sections were hybridized simultaneously with the DIG-labeled <italic>ara</italic> or <italic>arb</italic> probe and fluorescein-labeled <italic>esr1</italic> or <italic>esr2a</italic> probe. DIG was detected with a mouse anti-DIG antibody (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_304362">AB_304362</ext-link>; Abcam, Cambridge, UK) and visualized using the Alexa Fluor 555 Tyramide SuperBoost Kit, goat anti-mouse IgG (Thermo Fisher Scientific); fluorescein was detected with an anti-fluorescein antibody conjugated to horseradish peroxidase (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2737388">AB_2737388</ext-link>; PerkinElmer, Waltham, MA, USA) and visualized using the TSA Plus Fluorescein System (PerkinElmer). Cell nuclei were counterstained with DAPI. Fluorescent images were acquired with a Leica TCS SP8 confocal laser scanning microscope (Leica Microsystems, Wetzlar, Germany) and the following excitation/emission wavelengths: 552/620–700 nm (Alexa Fluor 555), 488/495–545 nm (fluorescein), and 405/410–480 nm (DAPI). Cells were identified as coexpressing the two genes when Alexa Fluor 555 and fluorescein signals were clearly observed in the cytoplasm surrounding DAPI-stained nuclei, with intensities markedly stronger than the background noise.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>All quantitative data were expressed as mean ± standard error of the mean (SEM). On graphs, individual data points were plotted to indicate the underlying distribution. Behavioral time-series data were analyzed using Kaplan-Meier plots with the inclusion of fish that did not exhibit the given act within the test period.</p><p>Statistical analyses were done using GraphPad Prism (GraphPad Software, San Diego, CA, USA). Data between two groups were compared using unpaired two-tailed Student’s <italic>t</italic> test. Welch’s correction was applied if the <italic>F</italic> test indicated that the variance between groups was significantly different. The Bonferroni-Dunn correction was applied for multiple comparisons between two groups. To compare data among more than two groups, one-way analysis of variance (ANOVA) was performed, followed by either Bonferroni’s (comparisons among experimental groups) or Dunnett’s (comparisons between untreated and E2-treated groups in <xref ref-type="fig" rid="fig4">Figure 4C and D</xref>) post hoc test. If the Brown-Forsythe test indicated a significant difference in variance across groups, the data were instead analyzed using the non-parametric Kruskal-Wallis test, followed by Dunn’s post hoc test. Differences between Kaplan-Meier curves were tested for significance using the Gehan-Breslow-Wilcoxon test (with Bonferroni’s correction for more than two comparisons). Fish that spawned without any courtship display were excluded from the analysis of courtship display because it was not appropriate to treat them either as fish that did not perform courtship displays within the test duration or as fish that performed the first courtship display 0 s before spawning. Specifically, 7/18 <italic>cyp19a1b</italic><sup>+/+</sup>, 11/18 <italic>cyp19a1b</italic><sup>+/−</sup>, and 6/18 <italic>cyp19a1b</italic><sup>−/−</sup> males were excluded in <xref ref-type="fig" rid="fig1">Figure 1E</xref>; 2/23 <italic>esr1</italic><sup>+/+</sup> and 5/24 <italic>esr1</italic><sup>−/−</sup> males were excluded in <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>; 2/24 <italic>esr2a</italic><sup>+/+</sup> and 3/23 <italic>esr2a</italic><sup>−/−</sup> males were excluded in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A</xref>; 0/23 <italic>esr2a</italic><sup>+/+</sup> and 0/23 <italic>esr2a</italic><sup>−/−</sup> males were excluded in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4B</xref>. All data points were included in the analyses and no outliers were defined.</p><p>No power analysis was conducted due to the lack of relevant data; sample size was estimated based on previous studies reporting inter-individual variation in behavior and neural gene expression in medaka.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>is an inventor on a patent application related to this work filed by Regional Fish Institute and the University of Tokyo (Japanese patent application no. JP2023-205555, filed on 5 December 2023)</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of the University of Tokyo. The committee requests the submission of an animal-use protocol only for use of mammals, birds, and reptiles, in accordance with the Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of Japan (Ministry of Education, Culture, Sports, Science and Technology, Notice No. 71; June 1, 2006). Accordingly, we did not submit an animal-use protocol for this study, which used only teleost fish and thus did not require approval by the committee.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-97106-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Abbreviations of brain nuclei.</title></caption><media xlink:href="elife-97106-supp1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Primers and probes used in this study.</title></caption><media xlink:href="elife-97106-supp2-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data supporting the findings of this study are included in the article and its supplementary information.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank NBRP Medaka for providing the BAC clones, managing the TILLING library, and performing artificial insemination; Dr. Yoshihito Taniguchi for constructing the TILLING library; Dr. Masatoshi Nakamoto for recovering the <italic>cyp19a1b</italic> mutant allele; Akira Hirata, Kaoru Furukawa, Tomiko Iba, and Ayu Kuwakubo for assistance with medaka husbandry.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Dunger</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Willmore</surname><given-names>L</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Bambrick</surname><given-names>J</given-names></name><name><surname>Bodenstein</surname><given-names>SW</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Hung</surname><given-names>CC</given-names></name><name><surname>O’Neill</surname><given-names>M</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Žemgulytė</surname><given-names>A</given-names></name><name><surname>Arvaniti</surname><given-names>E</given-names></name><name><surname>Beattie</surname><given-names>C</given-names></name><name><surname>Bertolli</surname><given-names>O</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Cherepanov</surname><given-names>A</given-names></name><name><surname>Congreve</surname><given-names>M</given-names></name><name><surname>Cowen-Rivers</surname><given-names>AI</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>FB</given-names></name><name><surname>Gladman</surname><given-names>H</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>YA</given-names></name><name><surname>Low</surname><given-names>CMR</given-names></name><name><surname>Perlin</surname><given-names>K</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Savy</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Stecula</surname><given-names>A</given-names></name><name><surname>Thillaisundaram</surname><given-names>A</given-names></name><name><surname>Tong</surname><given-names>C</given-names></name><name><surname>Yakneen</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>ED</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Bapst</surname><given-names>V</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Jaderberg</surname><given-names>M</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name><name><surname>Jumper</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Accurate structure prediction of biomolecular interactions with AlphaFold 3</article-title><source>Nature</source><volume>630</volume><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07487-w</pub-id><pub-id pub-id-type="pmid">38718835</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alward</surname><given-names>BA</given-names></name><name><surname>Laud</surname><given-names>VA</given-names></name><name><surname>Skalnik</surname><given-names>CJ</given-names></name><name><surname>York</surname><given-names>RA</given-names></name><name><surname>Juntti</surname><given-names>SA</given-names></name><name><surname>Fernald</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Modular genetic control of social status in a cichlid fish</article-title><source>PNAS</source><volume>117</volume><fpage>28167</fpage><lpage>28174</lpage><pub-id pub-id-type="doi">10.1073/pnas.2008925117</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anken</surname><given-names>R</given-names></name><name><surname>Bourrat</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1998">1998</year><source>Brain Atlas of the Medaka Fish</source><publisher-name>INRA Editions</publisher-name></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The role of steroid hormones in the sexual differentiation of the human brain</article-title><source>Journal of Neuroendocrinology</source><volume>34</volume><elocation-id>e13050</elocation-id><pub-id pub-id-type="doi">10.1111/jne.13050</pub-id><pub-id pub-id-type="pmid">34708466</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balthazart</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>New concepts in the study of the sexual differentiation and activation of reproductive behavior, a personal view</article-title><source>Frontiers in Neuroendocrinology</source><volume>55</volume><elocation-id>100785</elocation-id><pub-id pub-id-type="doi">10.1016/j.yfrne.2019.100785</pub-id><pub-id pub-id-type="pmid">31430485</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayley</surname><given-names>M</given-names></name><name><surname>Nielsen</surname><given-names>JR</given-names></name><name><surname>Baatrup</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Guppy sexual behavior as an effect biomarker of estrogen mimics</article-title><source>Ecotoxicology and Environmental Safety</source><volume>43</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1006/eesa.1999.1766</pub-id><pub-id pub-id-type="pmid">10330323</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Effects of an endocrine disrupter on courtship and aggressive behaviour of male three-spined stickleback,Gasterosteus aculeatus</article-title><source>Animal Behaviour</source><volume>62</volume><fpage>775</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1006/anbe.2001.1824</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjerselius</surname><given-names>R</given-names></name><name><surname>Lundstedt-Enkel</surname><given-names>K</given-names></name><name><surname>Olsén</surname><given-names>H</given-names></name><name><surname>Mayer</surname><given-names>I</given-names></name><name><surname>Dimberg</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Male goldfish reproductive behaviour and physiology are severely affected by exogenous exposure to 17beta-estradiol</article-title><source>Aquatic Toxicology</source><volume>53</volume><fpage>139</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/s0166-445x(00)00160-0</pub-id><pub-id pub-id-type="pmid">11311390</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diotel</surname><given-names>N</given-names></name><name><surname>Le Page</surname><given-names>Y</given-names></name><name><surname>Mouriec</surname><given-names>K</given-names></name><name><surname>Tong</surname><given-names>S-K</given-names></name><name><surname>Pellegrini</surname><given-names>E</given-names></name><name><surname>Vaillant</surname><given-names>C</given-names></name><name><surname>Anglade</surname><given-names>I</given-names></name><name><surname>Brion</surname><given-names>F</given-names></name><name><surname>Pakdel</surname><given-names>F</given-names></name><name><surname>Chung</surname><given-names>B</given-names></name><name><surname>Kah</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Aromatase in the brain of teleost fish: expression, regulation and putative functions</article-title><source>Frontiers in Neuroendocrinology</source><volume>31</volume><fpage>172</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.yfrne.2010.01.003</pub-id><pub-id pub-id-type="pmid">20116395</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diotel</surname><given-names>N</given-names></name><name><surname>Charlier</surname><given-names>TD</given-names></name><name><surname>Lefebvre d’Hellencourt</surname><given-names>C</given-names></name><name><surname>Couret</surname><given-names>D</given-names></name><name><surname>Trudeau</surname><given-names>VL</given-names></name><name><surname>Nicolau</surname><given-names>JC</given-names></name><name><surname>Meilhac</surname><given-names>O</given-names></name><name><surname>Kah</surname><given-names>O</given-names></name><name><surname>Pellegrini</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Steroid transport, local synthesis, and signaling within the brain: roles in neurogenesis, neuroprotection, and sexual behaviors</article-title><source>Frontiers in Neuroscience</source><volume>12</volume><elocation-id>84</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2018.00084</pub-id><pub-id pub-id-type="pmid">29515356</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>T</given-names></name><name><surname>Tachizawa</surname><given-names>M</given-names></name><name><surname>Nishiike</surname><given-names>Y</given-names></name><name><surname>Koiwa</surname><given-names>A</given-names></name><name><surname>Homan</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Estrogen-dependent expression and function of secretogranin 2a in female-specific peptidergic neurons</article-title><source>PNAS Nexus</source><volume>2</volume><elocation-id>pgad413</elocation-id><pub-id pub-id-type="doi">10.1093/pnasnexus/pgad413</pub-id><pub-id pub-id-type="pmid">38111823</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forlano</surname><given-names>PM</given-names></name><name><surname>Deitcher</surname><given-names>DL</given-names></name><name><surname>Myers</surname><given-names>DA</given-names></name><name><surname>Bass</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Anatomical distribution and cellular basis for high levels of aromatase activity in the brain of teleost fish: aromatase enzyme and mRNA expression identify glia as source</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>8943</fpage><lpage>8955</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-22-08943.2001</pub-id><pub-id pub-id-type="pmid">11698605</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gegenhuber</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>MV</given-names></name><name><surname>Bronstein</surname><given-names>R</given-names></name><name><surname>Tollkuhn</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Gene regulation by gonadal hormone receptors underlies brain sex differences</article-title><source>Nature</source><volume>606</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04686-1</pub-id><pub-id pub-id-type="pmid">35508660</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallgren</surname><given-names>SLE</given-names></name><name><surname>Linderoth</surname><given-names>M</given-names></name><name><surname>Olsén</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Inhibition of cytochrome p450 brain aromatase reduces two male specific sexual behaviours in the male Endler guppy (Poecilia reticulata)</article-title><source>General and Comparative Endocrinology</source><volume>147</volume><fpage>323</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.ygcen.2006.02.005</pub-id><pub-id pub-id-type="pmid">16563393</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiraki</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Tsumaki</surname><given-names>T</given-names></name><name><surname>Zempo</surname><given-names>B</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name><name><surname>Oka</surname><given-names>Y</given-names></name><name><surname>Nagahama</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Female-specific target sites for both oestrogen and androgen in the teleost brain</article-title><source>Proceedings. Biological Sciences</source><volume>279</volume><fpage>5014</fpage><lpage>5023</lpage><pub-id pub-id-type="doi">10.1098/rspb.2012.2011</pub-id><pub-id pub-id-type="pmid">23075834</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiraki-Kajiyama</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>J</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Kikuchi</surname><given-names>Y</given-names></name><name><surname>Nakajo</surname><given-names>M</given-names></name><name><surname>Miyazoe</surname><given-names>D</given-names></name><name><surname>Nishiike</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Hosono</surname><given-names>K</given-names></name><name><surname>Kawabata-Sakata</surname><given-names>Y</given-names></name><name><surname>Ansai</surname><given-names>S</given-names></name><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Nagahama</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuropeptide B mediates female sexual receptivity in medaka fish, acting in a female-specific but reversible manner</article-title><source>eLife</source><volume>8</volume><elocation-id>e39495</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39495</pub-id><pub-id pub-id-type="pmid">31383257</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffman</surname><given-names>LS</given-names></name><name><surname>O’Connell</surname><given-names>LA</given-names></name><name><surname>Hofmann</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Aromatase regulates aggression in the African cichlid fish Astatotilapia burtoni</article-title><source>Physiology &amp; Behavior</source><volume>112–113</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2013.02.004</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Yoshimoto</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A brain atlas of a wild-type inbred strain of the medaka, Oryzias latipes</article-title><source>The Fish Biology Journal Medaka</source><volume>10</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.18999/fisbjm.10.1</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalabert</surname><given-names>C</given-names></name><name><surname>Quintana</surname><given-names>L</given-names></name><name><surname>Pessina</surname><given-names>P</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Extra-gonadal steroids modulate non-breeding territorial aggression in weakly electric fish</article-title><source>Hormones and Behavior</source><volume>72</volume><fpage>60</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2015.05.003</pub-id><pub-id pub-id-type="pmid">25989595</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juntti</surname><given-names>SA</given-names></name><name><surname>Tollkuhn</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>MV</given-names></name><name><surname>Fraser</surname><given-names>EJ</given-names></name><name><surname>Soderborg</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Honda</surname><given-names>S-I</given-names></name><name><surname>Harada</surname><given-names>N</given-names></name><name><surname>Shah</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The androgen receptor governs the execution, but not programming, of male sexual and territorial behaviors</article-title><source>Neuron</source><volume>66</volume><fpage>260</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.03.024</pub-id><pub-id pub-id-type="pmid">20435002</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabata</surname><given-names>Y</given-names></name><name><surname>Hiraki</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sex differences in the expression of vasotocin/isotocin, gonadotropin-releasing hormone, and tyrosine and tryptophan hydroxylase family genes in the medaka brain</article-title><source>Neuroscience</source><volume>218</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.05.021</pub-id><pub-id pub-id-type="pmid">22609934</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabata-Sakata</surname><given-names>Y</given-names></name><name><surname>Nishiike</surname><given-names>Y</given-names></name><name><surname>Fleming</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Androgen-dependent sexual dimorphism in pituitary tryptophan hydroxylase expression: relevance to sex differences in pituitary hormones</article-title><source>Proceedings. Biological Sciences</source><volume>287</volume><elocation-id>20200713</elocation-id><pub-id pub-id-type="doi">10.1098/rspb.2020.0713</pub-id><pub-id pub-id-type="pmid">32517612</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabata-Sakata</surname><given-names>Y</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Male-specific vasotocin expression in the medaka tuberal hypothalamus: Androgen dependence and probable role in aggression</article-title><source>Molecular and Cellular Endocrinology</source><volume>580</volume><elocation-id>112101</elocation-id><pub-id pub-id-type="doi">10.1016/j.mce.2023.112101</pub-id><pub-id pub-id-type="pmid">37923055</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayo</surname><given-names>D</given-names></name><name><surname>Zempo</surname><given-names>B</given-names></name><name><surname>Tomihara</surname><given-names>S</given-names></name><name><surname>Oka</surname><given-names>Y</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gene knockout analysis reveals essentiality of estrogen receptor β1 (Esr2a) for female reproduction in medaka</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>8868</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-45373-y</pub-id><pub-id pub-id-type="pmid">31222039</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayo</surname><given-names>D</given-names></name><name><surname>Oka</surname><given-names>Y</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Examination of methods for manipulating serum 17β-Estradiol (E2) levels by analysis of blood E2 concentration in medaka (Oryzias latipes)</article-title><source>General and Comparative Endocrinology</source><volume>285</volume><elocation-id>113272</elocation-id><pub-id pub-id-type="doi">10.1016/j.ygcen.2019.113272</pub-id><pub-id pub-id-type="pmid">31525376</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Cho</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly</article-title><source>Genome Research</source><volume>19</volume><fpage>1279</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1101/gr.089417.108</pub-id><pub-id pub-id-type="pmid">19470664</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Li</surname><given-names>LH</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name><name><surname>Shin</surname><given-names>BA</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e18556</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0018556</pub-id><pub-id pub-id-type="pmid">21602908</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinge</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Estrogen receptor interaction with estrogen response elements</article-title><source>Nucleic Acids Research</source><volume>29</volume><fpage>2905</fpage><lpage>2919</lpage><pub-id pub-id-type="doi">10.1093/nar/29.14.2905</pub-id><pub-id pub-id-type="pmid">11452016</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lephart</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A review of brain aromatase cytochrome P450</article-title><source>Brain Research. Brain Research Reviews</source><volume>22</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/0165-0173(96)00002-1</pub-id><pub-id pub-id-type="pmid">8871783</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindeboom</surname><given-names>RGH</given-names></name><name><surname>Vermeulen</surname><given-names>M</given-names></name><name><surname>Lehner</surname><given-names>B</given-names></name><name><surname>Supek</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy</article-title><source>Nature Genetics</source><volume>51</volume><fpage>1645</fpage><lpage>1651</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0517-5</pub-id><pub-id pub-id-type="pmid">31659324</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynn</surname><given-names>SG</given-names></name><name><surname>Birge</surname><given-names>WJ</given-names></name><name><surname>Shepherd</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Molecular characterization and sex-specific tissue expression of estrogen receptor α (esr1), estrogen receptor βa (esr2a) and ovarian aromatase (cyp19a1a) in yellow perch (Perca flavescens)</article-title><source>Comparative Biochemistry and Physiology Part B</source><volume>149</volume><fpage>126</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.cbpb.2007.09.001</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinović</surname><given-names>D</given-names></name><name><surname>Hogarth</surname><given-names>WT</given-names></name><name><surname>Jones</surname><given-names>RE</given-names></name><name><surname>Sorensen</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Environmental estrogens suppress hormones, behavior, and reproductive fitness in male fathead minnows</article-title><source>Environmental Toxicology and Chemistry</source><volume>26</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1897/06-065r.1</pub-id><pub-id pub-id-type="pmid">17713215</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>MM</given-names></name><name><surname>Nugent</surname><given-names>BM</given-names></name><name><surname>Lenz</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain</article-title><source>Nature Reviews. Neuroscience</source><volume>18</volume><fpage>471</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1038/nrn.2017.61</pub-id><pub-id pub-id-type="pmid">28638119</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Neural control of sexually dimorphic social behavior: connecting development to adulthood</article-title><source>Annual Review of Neuroscience</source><volume>46</volume><fpage>321</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-121522-110856</pub-id><pub-id pub-id-type="pmid">37001242</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagahama</surname><given-names>Y</given-names></name><name><surname>Chakraborty</surname><given-names>T</given-names></name><name><surname>Paul-Prasanth</surname><given-names>B</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sex determination, gonadal sex differentiation, and plasticity in vertebrate species</article-title><source>Physiological Reviews</source><volume>101</volume><fpage>1237</fpage><lpage>1308</lpage><pub-id pub-id-type="doi">10.1152/physrev.00044.2019</pub-id><pub-id pub-id-type="pmid">33180655</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamoto</surname><given-names>M</given-names></name><name><surname>Shibata</surname><given-names>Y</given-names></name><name><surname>Ohno</surname><given-names>K</given-names></name><name><surname>Usami</surname><given-names>T</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>Y</given-names></name><name><surname>Todo</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>G</given-names></name><name><surname>Swanson</surname><given-names>P</given-names></name><name><surname>Naruse</surname><given-names>K</given-names></name><name><surname>Nagahama</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ovarian aromatase loss-of-function mutant medaka undergo ovary degeneration and partial female-to-male sex reversal after puberty</article-title><source>Molecular and Cellular Endocrinology</source><volume>460</volume><fpage>104</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2017.07.013</pub-id><pub-id pub-id-type="pmid">28711606</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiike</surname><given-names>Y</given-names></name><name><surname>Miyazoe</surname><given-names>D</given-names></name><name><surname>Togawa</surname><given-names>R</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Nakasone</surname><given-names>K</given-names></name><name><surname>Miyata</surname><given-names>M</given-names></name><name><surname>Kikuchi</surname><given-names>Y</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Todo</surname><given-names>T</given-names></name><name><surname>Ishikawa-Fujiwara</surname><given-names>T</given-names></name><name><surname>Ohno</surname><given-names>K</given-names></name><name><surname>Usami</surname><given-names>T</given-names></name><name><surname>Nagahama</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Estrogen receptor 2b is the major determinant of sex-typical mating behavior and sexual preference in medaka</article-title><source>Current Biology</source><volume>31</volume><fpage>1699</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2021.01.089</pub-id><pub-id pub-id-type="pmid">33639108</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiike</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The decision of male medaka to mate or fight depends on two complementary androgen signaling pathways</article-title><source>PNAS</source><volume>121</volume><elocation-id>e2316459121</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2316459121</pub-id><pub-id pub-id-type="pmid">38781215</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connell</surname><given-names>LA</given-names></name><name><surname>Hofmann</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Social status predicts how sex steroid receptors regulate complex behavior across levels of biological organization</article-title><source>Endocrinology</source><volume>153</volume><fpage>1341</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1210/en.2011-1663</pub-id><pub-id pub-id-type="pmid">22166981</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name><name><surname>Choleris</surname><given-names>E</given-names></name><name><surname>Vasudevan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estrogenic regulation of social behavior and sexually dimorphic brain formation</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>110</volume><fpage>46</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.10.012</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogino</surname><given-names>Y</given-names></name><name><surname>Ansai</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>E</given-names></name><name><surname>Yasugi</surname><given-names>M</given-names></name><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Sakamoto</surname><given-names>H</given-names></name><name><surname>Okamoto</surname><given-names>K</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Hara</surname><given-names>I</given-names></name><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>A</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Naruse</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>K</given-names></name><name><surname>Ogino</surname><given-names>H</given-names></name><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Miyagawa</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>ME</given-names></name><name><surname>Iguchi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Evolutionary differentiation of androgen receptor is responsible for sexual characteristic development in a teleost fish</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>1428</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-37026-6</pub-id><pub-id pub-id-type="pmid">36918573</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Chaube</surname><given-names>R</given-names></name><name><surname>Paul-Prasanth</surname><given-names>B</given-names></name><name><surname>Kanda</surname><given-names>S</given-names></name><name><surname>Oka</surname><given-names>Y</given-names></name><name><surname>Nagahama</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sex differences in aromatase gene expression in the medaka brain</article-title><source>Journal of Neuroendocrinology</source><volume>23</volume><fpage>412</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.2011.02120.x</pub-id><pub-id pub-id-type="pmid">21332842</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Okubo</surname><given-names>K</given-names></name><name><surname>Nishiike</surname><given-names>Y</given-names></name><name><surname>Fleming</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>Y</given-names></name><name><surname>Hiraki-Kajiyama</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><chapter-title>Sex steroid regulation of male- and female-typical mating behaviors in teleost fish</chapter-title><person-group person-group-type="editor"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Tachibana</surname><given-names>M</given-names></name></person-group><source>Spectrum of Sex</source><publisher-name>Springer Nature</publisher-name><fpage>111</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/978-981-19-5359-0_7</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshima</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>IJ</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Imada</surname><given-names>N</given-names></name><name><surname>Honjo</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Suppression of sexual behavior in male Japanese medaka (Oryzias latipes) exposed to 17beta-estradiol</article-title><source>Chemosphere</source><volume>50</volume><fpage>429</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/s0045-6535(02)00494-0</pub-id><pub-id pub-id-type="pmid">12656264</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Post-proliferative immature radial glial cells female-specifically express aromatase in the medaka optic tectum</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e73663</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0073663</pub-id><pub-id pub-id-type="pmid">24019933</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Furutani-Seiki</surname><given-names>M</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Todo</surname><given-names>T</given-names></name><name><surname>Sasado</surname><given-names>T</given-names></name><name><surname>Deguchi</surname><given-names>T</given-names></name><name><surname>Kondoh</surname><given-names>H</given-names></name><name><surname>Mudde</surname><given-names>J</given-names></name><name><surname>Yamazoe</surname><given-names>M</given-names></name><name><surname>Hidaka</surname><given-names>M</given-names></name><name><surname>Mitani</surname><given-names>H</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Sakaki</surname><given-names>Y</given-names></name><name><surname>Plasterk</surname><given-names>RHA</given-names></name><name><surname>Cuppen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Generation of medaka gene knockout models by target-selected mutagenesis</article-title><source>Genome Biology</source><volume>7</volume><elocation-id>R116</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2006-7-12-r116</pub-id><pub-id pub-id-type="pmid">17156454</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terasawa</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuroestradiol in regulation of GnRH release</article-title><source>Hormones and Behavior</source><volume>104</volume><fpage>138</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2018.04.003</pub-id><pub-id pub-id-type="pmid">29626484</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>J</given-names></name><name><surname>Zehr</surname><given-names>JL</given-names></name><name><surname>Loose</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Effects of prenatal androgens on rhesus monkeys: a model system to explore the organizational hypothesis in primates</article-title><source>Hormones and Behavior</source><volume>55</volume><fpage>633</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2009.03.015</pub-id><pub-id pub-id-type="pmid">19446080</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripp</surname><given-names>JA</given-names></name><name><surname>Salas-Allende</surname><given-names>I</given-names></name><name><surname>Makowski</surname><given-names>A</given-names></name><name><surname>Bass</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mating behavioral function of preoptic galanin neurons is shared between fish with alternative male reproductive tactics and tetrapods</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>1549</fpage><lpage>1559</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1276-19.2019</pub-id><pub-id pub-id-type="pmid">31911461</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukahara</surname><given-names>S</given-names></name><name><surname>Morishita</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sexually dimorphic formation of the preoptic area and the bed nucleus of the stria terminalis by neuroestrogens</article-title><source>Frontiers in Neuroscience</source><volume>14</volume><elocation-id>797</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2020.00797</pub-id><pub-id pub-id-type="pmid">32848568</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>J</given-names></name><name><surname>Takeuchi</surname><given-names>A</given-names></name><name><surname>Hosono</surname><given-names>K</given-names></name><name><surname>Fleming</surname><given-names>T</given-names></name><name><surname>Nagahama</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Male-predominant galanin mediates androgen-dependent aggressive chases in medaka</article-title><source>eLife</source><volume>9</volume><elocation-id>e59470</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.59470</pub-id><pub-id pub-id-type="pmid">32783809</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoi</surname><given-names>S</given-names></name><name><surname>Okuyama</surname><given-names>T</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Naruse</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>Y</given-names></name><name><surname>Ansai</surname><given-names>S</given-names></name><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name><name><surname>Takemori</surname><given-names>N</given-names></name><name><surname>Kubo</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An essential role of the arginine vasotocin system in mate-guarding behaviors in triadic relationships of medaka fish (Oryzias latipes)</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005009</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005009</pub-id><pub-id pub-id-type="pmid">25719383</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>L</given-names></name><name><surname>Thet</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic editing of the androgen receptor contributes to impaired male courtship behavior in zebrafish</article-title><source>The Journal of Experimental Biology</source><volume>220</volume><fpage>3017</fpage><lpage>3021</lpage><pub-id pub-id-type="doi">10.1242/jeb.161596</pub-id><pub-id pub-id-type="pmid">28620015</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Min</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mutation of cyp19a1b results in sterile males due to efferent duct obstruction in Nile tilapia</article-title><source>Molecular Reproduction and Development</source><volume>86</volume><fpage>1224</fpage><lpage>1235</lpage><pub-id pub-id-type="doi">10.1002/mrd.23237</pub-id><pub-id pub-id-type="pmid">31339195</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zilkha</surname><given-names>N</given-names></name><name><surname>Sofer</surname><given-names>Y</given-names></name><name><surname>Kashash</surname><given-names>Y</given-names></name><name><surname>Kimchi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The social network: Neural control of sex differences in reproductive behaviors, motivation, and response to social isolation</article-title><source>Current Opinion in Neurobiology</source><volume>68</volume><fpage>137</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2021.03.005</pub-id><pub-id pub-id-type="pmid">33910083</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97106.4.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Taffe</surname><given-names>Michael A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This is an overall <bold>compelling</bold> set of findings on the role of centrally produced estrogens in the control of behaviors in male medaka. The significance of the findings rests on the revealed potential mechanism between brain derived estrogens modulating social behaviors in males, supported by the analysis of multiple transgenic lines. The evidence for the broader claim is incomplete since it has not been extended to female medaka, and further experimentation would be necessary to fully validate the conclusions on the role of brain-derived estrogens. Nonetheless, the findings have led to <bold>important</bold> hypotheses on the hormonal control of behaviors in teleosts that can be tested further.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97106.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This research group has consistently performed cutting-edge research aiming to understand the role of hormones in the control of social behaviors, specifically by utilizing the genetically-tractable teleost fish, medaka, and the current work is no exception. The overall claim they make, that estrogens modulate social behaviors in males is supported, with important caveats. For one, there is no evidence these estrogens are generated by &quot;neurons&quot; as would be assumed by their main claim that it is NEUROestrogens that drive this effect. While indeed the aromatase they have investigated is expressed solely in the brain, in most teleosts, brain aromatase is only present in glial cells (astrocytes, radial glia). The authors should change this description so as not to mislead the reader. Below I detail more specific strengths and weaknesses of this manuscript.</p><p>Strengths:</p><p>Excellent use of the medaka model to disentangle the control of social behavior by sex steroid hormones</p><p>The findings are strong for the most part because deficits in the mutants are restored by the molecule (estrogens) that was no longer present due to the mutation</p><p>Presentation of the approach and findings are clear, allowing the reader to make their own inferences and compare them with the authors'</p><p>Includes multiple follow-up experiments, which leads to tests of internal replication and an impactful mechanistic proposal</p><p>Findings are provocative not just for teleost researchers, but for other species since, as the authors point out, the data suggest mechanisms of estrogenic control of social behaviors may be evolutionary ancient</p><p>Weaknesses:</p><p>The experimental design for studying aggression in males has flaws, but it appears a typical resident-intruder type assay is not appropriate for medaka. seems other species may be better for studying aggression in teleosts.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97106.4.sa2</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Taking advantage of the existence in fish of two genes coding for estrogen synthase, the enzyme aromatase, one mostly expressed in the brain (Cyp19a1b) and the other mostly found in the gonads (Cyp19a1a), this study investigates the role of brain-derived estrogens in the control of sexual and aggressive behavior in male medaka. The constitutive deletion of Cyp19a1b, confirmed by the ablation of its transcript, markedly reduced brain estrogen content. This effect is accompanied by reduced sexual and aggressive behavior and reduced expression of the transcripts coding for androgen receptors (AR), ara and arb, in brain regions involved in social behavior regulation. Both AR expression and aspects of social behaviors were restored by adult treatment with estrogens, providing some support for a role of aromatization. Expression analysis of AR isoforms and behavior of mutants of estrogen receptors (ER) indicates that these effects are likely mediated by the activation of the esr1 and esr2a isoforms. Together, these results provide valuable insights into the role of brain-derived estrogens in social behavior in fish.</p><p>Strengths:</p><p>This study evaluates the role of brain &quot;specific&quot; Cyp19a1 in the social behavior in male teleost fish, which as a taxon are more abundant and yet proportionally less studied that the most common birds and rodents. Therefore, evaluating the generalizability of results from higher vertebrates is important. The study suggests that, as opposed to mammals, the facilitatory role of brain-derived estrogens on mating and aggression is limited to adulthood.</p><p>Results obtained from multiple mutant lines converge to show that estrogens most likely synthesized in the brain drives aspects of male sexual behavior.</p><p>The comparative discussion of the age-dependent abundance of brain aromatase in fish vs mammals and its role in organization vs activation is important beyond the study of the targeted species.</p><p>Weaknesses:</p><p>Most experiments are weakly powered (low sample size).</p><p>The variability of the mRNA content for a same target gene between experiments (genotype comparison vs E2 treatment comparison) raises questions about the reproducibility of the data (apparent disappearance of genotype effect).</p><p>Conclusions :</p><p>Overall, the present study provides convincing evidence for a facilitatory role of estrogens originating from the brain on sexual behavior and aggressive behavior in male medaka. The role of specific estrogen receptor isoforms underlying the expression of androgen receptors is supported by converging evidence from multiple mutant lines.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.97106.4.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nishiike</surname><given-names>Yuji</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Tokyo</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Maki</surname><given-names>Shizuku</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Tokyo</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Miyazoe</surname><given-names>Daichi</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Tokyo</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Nakasone</surname><given-names>Kiyoshi</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Tokyo</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Kamei</surname><given-names>Yasuhiro</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute for Basic Biology</institution><addr-line><named-content content-type="city">Okazaki</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Todo</surname><given-names>Takeshi</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Osaka</institution><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ishikawa-Fujiwara</surname><given-names>Tomoko</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Osaka</institution><addr-line><named-content content-type="city">Suita</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Ohno</surname><given-names>Kaoru</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute for Basic Biology</institution><addr-line><named-content content-type="city">Okazaki</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Usami</surname><given-names>Takeshi</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute for Basic Biology</institution><addr-line><named-content content-type="city">Okazaki</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Nagahama</surname><given-names>Yoshitaka</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute for Basic Biology</institution><addr-line><named-content content-type="city">Okazaki</named-content></addr-line><country>Japan</country></aff></contrib><contrib contrib-type="author"><name><surname>Okubo</surname><given-names>Kataaki</given-names></name><role specific-use="author">Author</role><aff><institution>The University of Tokyo</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>This research group has consistently performed cutting-edge research aiming to understand the role of hormones in the control of social behaviors, specifically by utilizing the genetically-tractable teleost fish, medaka, and the current work is no exception. The overall claim they make, that estrogens modulate social behaviors in males and females is supported, with important caveats. For one, there is no evidence these estrogens are generated by &quot;neurons&quot; as would be assumed by their main claim that it is NEUROestrogens that drive this effect. While indeed the aromatase they have investigated is expressed solely in the brain, in most teleosts, brain aromatase is only present in glial cells (astrocytes, radial glia). The authors should change this description so as not to mislead the reader. Below I detail more specific strengths and weaknesses of this manuscript.</p></disp-quote><p>We thank the reviewer for this positive evaluation of our work and for the helpful comments and suggestions. Regarding the concern that the term “neuroestrogens” may be misleading, we addressed this in the previous revision by consistently replacing it throughout the manuscript with “brain-derived estrogens” or “brain estrogens.”</p><p>In addition, the following sentence was added to the Introduction (line 61): “In teleost brains, including those of medaka, aromatase is exclusively localized in radial glial cells, in contrast to its neuronal localization in rodent brains (Forlano et al., 2001; Diotel et al., 2010; Takeuchi and Okubo, 2013).”</p><disp-quote content-type="editor-comment"><p>Strenghth:</p><p>Excellent use of the medaka model to disentangle the control of social behavior by sex steroid hormones</p><p>The findings are strong for the most part because deficits in the mutants are restored by the molecule (estrogens) that was no longer present due to the mutation</p><p>Presentation of the approach and findings are clear, allowing the reader to make their own inferences and compare them with the authors'</p><p>Includes multiple follow-up experiments, which leads to tests of internal replication and an impactful mechanistic proposal</p><p>Findings are provocative not just for teleost researchers, but for other species since, as the authors point out, the data suggest mechanisms of estrogenic control of social behaviors may be evolutionary ancient</p></disp-quote><p>We thank the reviewer again for their positive evaluation of our work.</p><disp-quote content-type="editor-comment"><p>Weakness:</p><p>As stated in the summary, the authors are attributing the estrogen source to neurons and there isn't evidence this is the case. The impact of the findings doesn't rest on this either</p></disp-quote><p>As mentioned above, we addressed this in the previous revision by replacing “neuroestrogens” with “brain-derived estrogens” or “brain estrogens” throughout the manuscript. In addition, the following sentence was added to the Introduction (line 61): “In teleost brains, including those of medaka, aromatase is exclusively localized in radial glial cells, in contrast to its neuronal localization in rodent brains (Forlano et al., 2001; Diotel et al., 2010; Takeuchi and Okubo, 2013).”</p><disp-quote content-type="editor-comment"><p>The d4 versus d8 esr2a mutants showed different results for aggression. The meaning and implications of this finding are not discussed, leaving the reader wondering</p></disp-quote><p>This comment is the same as one raised in the first review (Reviewer #1’s comment 2 on weaknesses), which we already addressed in our initial revision. For the reviewer’s convenience, we provide the response below:</p><p>Line 300: As the reviewer correctly noted, circles were significantly reduced in mutant males of the Δ8 line, whereas no significant reduction was observed in those of the Δ4 line. However, a tendency toward reduction was evident in the Δ4 line (P = 0.1512), and both lines showed significant differences in fin displays. Based on these findings, we believe our conclusion that esr2a<sup>−/−</sup> males exhibit reduced aggression remains valid. To clarify this point and address potential reader concerns, we have revised the text as follows: “esr2a<sup>−/−</sup> males exhibited significantly fewer fin displays (P = 0.0461 and 0.0293 for Δ8 and Δ4 lines, respectively) and circles (P = 0.0446 and 0.1512 for Δ8 and Δ4 lines, respectively) than their wild-type siblings (Fig. 5L; Fig. S8E), suggesting less aggression” was edited to read “esr2a<sup>−/−</sup> males from both the Δ8 and Δ4 lines exhibited significantly fewer fin displays than their wild-type siblings (P = 0.0461 and 0.0293, respectively). Circles followed a similar pattern, with a significant reduction in the Δ8 line (P = 0.0446) and a comparable but non-significant decrease in the Δ4 line (P = 0.1512) (Figure 5L, Figure 5—figure supplement 3E), showing less aggression.”</p><disp-quote content-type="editor-comment"><p>Lack of attribution of previous published work from other research groups that would provide the proper context of the present study</p></disp-quote><p>This comment is also the same as one raised in the first review (Reviewer #1’s comment 3 on weaknesses). In our previous revision, in response to this comment, we cited the relevant references (Hallgren et al., 2006; O’Connell and Hofmann, 2012; Huffman et al., 2013; Jalabert et al., 2015; Yong et al., 2017; Alward et al., 2020; Ogino et al., 2023) in the appropriate sections. We also added the following new references and revised the Introduction and Discussion accordingly:</p><p>(2) Alward BA, Laud VA, Skalnik CJ, York RA, Juntti SA, Fernald RD. 2020. Modular genetic control of social status in a cichlid fish. Proceedings of the National Academy of Sciences of the United States of America 117:28167–28174. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.2008925117">https://doi.org/10.1073/pnas.2008925117</ext-link></p><p>(39) O’Connell LA, Hofmann HA. 2012. Social status predicts how sex steroid receptors regulate complex behavior across levels of biological organization. Endocrinology 153:1341–1351. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/en.2011-1663">https://doi.org/10.1210/en.2011-1663</ext-link></p><p>(54) Yong L, Thet Z, Zhu Y. 2017. Genetic editing of the androgen receptor contributes to impaired male courtship behavior in zebrafish. Journal of Experimental Biology 220:3017–3021. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jeb.161596">https://doi.org/10.1242/jeb.161596</ext-link></p><disp-quote content-type="editor-comment"><p>There are a surprising number of citations not included; some of the ones not included argue against the authors' claims that their findings were &quot;contrary to expectation&quot;</p></disp-quote><p>In our previous revision, we cited the relevant references (Hallgren et al., 2006; O’Connell and Hofmann, 2012; Huffman et al., 2013; Jalabert et al., 2015) in the Introduction. We also revised the text to remove phrases such as “contrary to expectation” and “unexpected.”</p><disp-quote content-type="editor-comment"><p>The experimental design for studying aggression in males has flaws. A standard test like a residentintruder test should be used.</p></disp-quote><p>Following this comment, we have attempted additional aggression assays using the resident-intruder paradigm. However, these experiments did not produce consistent or interpretable results. As noted in our previous revision, medaka naturally form shoals and exhibit weak territoriality, and even slight differences in dominance between a resident and an intruder can markedly increase variability, reducing data reliability. Therefore, we believe that the approach used in the present study provides a more suitable assessment of aggression in medaka, regardless of territorial tendencies. We will continue to explore potential refinements in future studies and respectfully ask the reviewer to evaluate the present work based on the assay used here.</p><disp-quote content-type="editor-comment"><p>While they investigate males and females, there are fewer experiments and explanations for the female results, making it feel like a small addition or an aside</p></disp-quote><p>While we did not adopt this comment in our previous revision, we have carefully reconsidered the reviewers’ feedback and have now decided to remove the female data. This change allows us to present a more focused and cohesive story centered on males. The specific revisions are outlined below:</p><p>Abstract</p><p>Line 25: The text “, thereby revealing a previously unappreciated mode of action of brain-derived estrogens. We additionally show that female fish lacking Cyp19a1b are less receptive to male courtship and conversely court other females, highlighting the significance of brain-derived estrogens in establishing sex-typical behaviors in both sexes.” has been revised to “. Taken together, these findings reveal a previously unappreciated mode of action of brain-derived estrogens in shaping male-typical behaviors.”</p><p>Results</p><p>Line 88: The text “Loss of cyp19a1b function in these fish was verified by measuring brain and peripheral levels of sex steroids. As expected, brain estradiol-17β (E2) in both male and female homozygous mutants (cyp19a1b<sup>−/−</sup>) was significantly reduced to 16% and 50%, respectively, of the levels in their wild-type (cyp19a1b<sup>+/+</sup>) siblings (P = 0.0037, males; P = 0.0092, females) (Fig. 1, A and B). In males, brain E2 in heterozygotes (cyp19a1b<sup>−/−</sup>) was also reduced to 45% of the level in wild-type siblings (P = 0.0284) (Fig. 1A), indicating a dosage effect of cyp19a1b mutation. In contrast, peripheral E2 levels were unaltered in both cyp19a1b<sup>−/−</sup> males and females (Fig. S1, C and D), consistent with the expected functioning of Cyp19a1b primarily in the brain. Strikingly, brain levels of testosterone, as opposed to E2, increased 2.2-fold in cyp19a1b<sup>−/−</sup> males relative to wild-type siblings (P = 0.0006) (Fig. 1A). Similarly, brain 11KT levels in cyp19a1b<sup>−/−</sup> males and females increased 6.2- and 1.9-fold, respectively, versus wild-type siblings (P = 0.0007, males; P = 0.0316, females) (Fig. 1, A and B). These results show that cyp19a1b-deficient fish have reduced estrogen levels coupled with increased androgen levels in the brain, confirming the loss of cyp19a1b function. They also suggest that the majority of estrogens in the male brain and half of those in the female brain are synthesized locally in the brain. In addition, peripheral 11KT levels in cyp19a1b<sup>−/−</sup> males and females increased 3.7- and 1.8-fold, respectively (P = 0.0789, males; P = 0.0118, females) (Fig. S1, C and D), indicating peripheral influence in addition to central effects.” has been revised to “Loss of cyp19a1b function in these fish was verified by measuring brain and peripheral levels of sex steroids in males. As expected, brain estradiol-17β (E2) in homozygous mutants (cyp19a1b<sup>−/−</sup>) was significantly reduced to 16% of the levels in wild-type (cyp19a1b<sup>+/+</sup>) siblings (P = 0.0037) (Figure 1A). Brain E2 in heterozygotes (cyp19a1b<sup>+/−</sup>) was also reduced to 45% of wild-type levels (P = 0.0284) (Figure 1A), indicating a dosage effect of the cyp19a1b mutation. In contrast, peripheral E2 levels were unaltered in cyp19a1b<sup>−/−</sup> males (Figure 1B), consistent with the expected functioning of Cyp19a1b primarily in the brain. Strikingly, brain testosterone levels, as opposed to E2, increased 2.2-fold in cyp19a1b<sup>−/−</sup> males relative to wild-type siblings (P = 0.0006) (Figure 1A). Similarly, brain 11KT levels increased 6.2-fold (P = 0.0007) (Figure 1A). These results indicate that cyp19a1b-deficient males have reduced estrogen coupled with elevated androgen levels in the brain, confirming the loss of cyp19a1b function. They also suggest that the majority of estrogens in the male brain are synthesized locally in the brain. Peripheral 11KT levels also increased 3.7-fold in cyp19a1b<sup>−/−</sup> males (P = 0.0789) (Figure 1B), indicating peripheral influence in addition to central effects.”</p><p>Line 211: “expression of vt in the pNVT of cyp19a1b<sup>−/−</sup> males was significantly reduced to 18% as compared with cyp19a1b<sup>+/+</sup> males (P = 0.0040), a level comparable to that observed in females” has been revised to “expression of vt in the pNVT of cyp19a1b<sup>−/−</sup> males was significantly reduced to 18% as compared with cyp19a1b<sup>+/+</sup> males (P = 0.0040).”</p><p>The subsection entitled “cyp19a1b-deficient females are less receptive to males and instead court other females,” which followed line 311, has been removed.</p><p>Discussion</p><p>The two paragraphs between lines 373 and 374, which addressed the female data, have been removed.</p><p>Materials and methods</p><p>Line 433: “males and females” has been changed to “males”.</p><p>Line 457: “focal fish” has been changed to “focal male”.</p><p>Line 458: “stimulus fish” has been changed to “stimulus female”.</p><p>Line 458: “Fig. 6, E and F, ” has been deleted.</p><p>Line 460: “; wild-type males in Fig. 6, A to C” has been deleted.</p><p>Line 466: The text “The period of interaction/recording was extended to 2 hours in tests of courtship displays received from the stimulus esr2b-deficient female and in tests of mating behavior between females, because they take longer to initiate courtship (12). In tests using an esr2b-deficient female as the stimulus fish, where the latency to spawn could not be calculated because these fish were unreceptive to males and did not spawn, the sexual motivation of the focal fish was instead assessed by counting the number of courtship displays and wrapping attempts in 30 min. The number of these mating acts was also counted in tests to evaluate the receptivity of females. In tests of mating behavior between two females, the stimulus female was marked with a small notch in the caudal fin to distinguish it from the focal female.” has been revised to “In tests using an esr2b-deficient female as the stimulus fish, the latency to spawn could not be calculated because the female was unreceptive to males and did not spawn. Therefore, the sexual motivation of the focal male was assessed by counting the number of courtship displays and wrapping attempts in 30 min. To evaluate courtship displays performed by stimulus esr2bdeficient females toward focal males, the recording period was extended to 2 hours, as these females take longer to initiate courtship (Nishiike et al., 2021). In all video analyses, the researcher was blind to the fish genotype and treatment.”</p><p>Line 499: “brains dissected from males and females of the cyp19a1b-deficient line (analysis of ara, arb, vt, gal, npba, and esr2b) and males of the esr1-, esr2a-, and esr2b-deficient lines” has been revised to “male brains from the cyp19a1b-deficient line (analysis of ara, arb, vt, and gal) and from the esr1-, esr2a-, and esr2b-deficient lines.”</p><p>Line 504: “After color development for 15 min (gal), 40 min (npba), 2 hours (vt), or overnight (ara, arb, and esr2b)” has been revised to “After color development for 15 min (gal), 2 hours (vt), or overnight (ara and arb).”</p><p>Line 516: “Thermo Fisher Scientific, Waltham, MA” has been changed to “Thermo Fisher Scientific” to avoid redundancy.</p><p>Line 565: The subsection entitled “Measurement of spatial distances between fish” has been removed.</p><p>Line 585: “6/10 cyp19a1b<sup>+/+</sup>, 3/10 cyp19a1b<sup>+/−</sup>, and 6/10 cyp19a1b<sup>−/−</sup> females were excluded in Fig. 6B;” has been deleted.</p><p>References</p><p>The following references have been removed:</p><p>Capel B. 2017. Vertebrate sex determination: evolutionary plasticity of a fundamental switch. Nature Reviews Genetics 18:675–689. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrg.2017.60">https://doi.org/10.1038/nrg.2017.60</ext-link></p><p>Hiraki T, Nakasone K, Hosono K, Kawabata Y, Nagahama Y, Okubo K. 2014. Neuropeptide B is femalespecifically expressed in the telencephalic and preoptic nuclei of the medaka brain. Endocrinology 155:1021–1032. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/en.2013-1806">https://doi.org/10.1210/en.2013-1806</ext-link></p><p>Juntti SA, Hilliard AT, Kent KR, Kumar A, Nguyen A, Jimenez MA, Loveland JL, Mourrain P, Fernald RD. 2016. A neural basis for control of cichlid female reproductive behavior by prostaglandin F2α. Current Biology 26:943–949. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cub.2016.01.067">https://doi.org/10.1016/j.cub.2016.01.067</ext-link></p><p>Kimchi T, Xu J, Dulac C. 2007. A functional circuit underlying male sexual behaviour in the female mouse brain. Nature 448:1009–1014. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature06089">https://doi.org/10.1038/nature06089</ext-link></p><p>Kobayashi M, Stacey N. 1993. Prostaglandin-induced female spawning behavior in goldfish (Carassius auratus) appears independent of ovarian influence. Hormones and Behavior 27:38–55. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1006/hbeh.1993.1004">https://doi.org/10.1006/hbeh.1993.1004</ext-link></p><p>Liu H, Todd EV, Lokman PM, Lamm MS, Godwin JR, Gemmell NJ. 2017. Sexual plasticity: a fishy tale. Molecular Reproduction and Development 84:171–194. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/mrd.22691">https://doi.org/10.1002/mrd.22691</ext-link></p><p>Munakata A, Kobayashi M. 2010. Endocrine control of sexual behavior in teleost fish. General and Comparative Endocrinology 165:456–468. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ygcen.2009.04.011">https://doi.org/10.1016/j.ygcen.2009.04.011</ext-link></p><p>Nugent BM, Wright CL, Shetty AC, Hodes GE, Lenz KM, Mahurkar A, Russo SJ, Devine SE, McCarthy MM. 2015. Brain feminization requires active repression of masculinization via DNA methylation. Nature Neuroscience 18:690–697. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nn.3988">https://doi.org/10.1038/nn.3988</ext-link></p><p>Shaw K, Therrien M, Lu C, Liu X, Trudeau VL. 2023. Mutation of brain aromatase disrupts spawning behavior and reproductive health in female zebrafish. Frontiers in Endocrinology 14:1225199. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2023.1225199">https://doi.org/10.3389/fendo.2023.1225199</ext-link></p><p>Stacey NE. 1976. Effects of indomethacin and prostaglandins on the spawning behaviour of female goldfish. Prostaglandins 12:113–126. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0090-6980(76)80010-x">https://doi.org/10.1016/s0090-6980(76)80010-x</ext-link></p><p>Figure 1</p><p>Panel B, which originally showed steroid levels in female brains, has been replaced with steroid levels in the periphery of males, originally presented in Figure S1, panel C. Accordingly, the legend “(A and B) Levels of E2, testosterone, and 11KT in the brain of adult cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males (A) and females (B) (n = 3 per genotype and sex).” has been revised to “(A, B) Levels of E2, testosterone, and 11KT in the brain (A) and periphery (B) of adult cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males (n = 3 per genotype).”</p><p>Figure 3</p><p>The female data have been deleted from Figure 3. The revised Figure 3 is presented.</p><p>The corresponding legend text has been revised as follows:</p><p>Line 862: “males and females (n = 4 and 5 per genotype for males and females, respectively)” has been changed to “males (n = 4 per genotype)”.</p><p>Line 864: “males and females (n = 4 except for cyp19a1b<sup>+/+</sup> males, where n = 3)” has been changed to “males (n = 3 and 4, respectively)”.</p><p>Figure 6</p><p>Figure 6 and its legend have been removed.</p><p>Figure 1—figure supplement 1</p><p>Panel C, showing male data, has been moved to Figure 1B, as described above, while panel D, showing female data, has been deleted. The corresponding legend “(<bold>C</bold> and <bold>D</bold>) Levels of E2, testosterone, and 11KT in the periphery of adult cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males (C) and females (D) (n = 3 per genotype and sex). Statistical differences were assessed by Bonferroni’s post hoc test (C and D). Error bars represent SEM. *P &lt; 0.05.” has also been removed.</p><p>Line 804: Following this change, the figure title has been updated from “Generation of cyp19a1bdeficient medaka and evaluation of peripheral sex steroid levels” to “Generation of cyp19a1b-deficient medaka.”</p><disp-quote content-type="editor-comment"><p>The statistics comparing &quot;experimental to experimental&quot; and &quot;control to experimental&quot; isn't appropriate</p></disp-quote><p>This comment is the same as one raised in the first review (Reviewer #1’s comment 7 on weaknesses), which we already addressed in our initial revision. For the reviewer’s convenience, we provide the response below:</p><p>The reviewer raised concerns about the statistical analysis used for Figures 4C and 4E, suggesting that Bonferroni’s test should be used instead of Dunnett’s test. However, Dunnett’s test is commonly used to compare treatment groups to a reference group that receives no treatment, as in our study. Since we do not compare the treated groups with each other, we believe Dunnett’s test is the most appropriate choice.</p><p>Line 576: The reviewer’s concern may have arisen from the phrase “comparisons between control and experimental groups” in the Materials and methods. We have revised it to “comparisons between untreated and E2-treated groups in Figure 4C and D” for clarity.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>Summary:</p><p>Taking advantage of the existence in fish of two genes coding for estrogen synthase, the enzyme aromatase, one mostly expressed in the brain (Cyp19a1b) and the other mostly found in the gonads (Cyp19a1a), this study investigates the role of brain-derived estrogens in the control of sexual and aggressive behavior in medaka. The constitutive deletion of Cyp19a1b markedly reduced brain estrogen content in males and to a lesser extent in females. These effects are accompanied by reduced sexual and aggressive behavior in males and reduced preference for males in females. These effects are reversed by adult treatment with supporting a role for estrogens. The deletion of Cyp19a1b is associated with a reduced expression of the genes coding for the two androgen receptors, ara and arb, in brain regions involved in the regulation of social behavior. The analysis of the gene expression and behavior of mutants of estrogen receptors indicates that these effects are likely mediated by the activation of the esr1 and esr2a isoforms. These results provide valuable insight into the role of estrogens in social behavior in the most abundant vertebrate taxon, however the conclusion of brain-derived estrogens awaits definitive confirmation.</p></disp-quote><p>We thank this reviewer for their positive evaluation of our work and comments that have improved the manuscript.</p><disp-quote content-type="editor-comment"><p>Strength:</p><p>Evaluation of the role of brain &quot;specific&quot; Cyp19a1 in male teleost fish, which as a taxon are more abundant and yet proportionally less studied that the most common birds and rodents. Therefore, evaluating the generalizability of results from higher vertebrates is important. This approach also offers great potential to study the role of brain estrogen production in females, an understudied question in all taxa.</p><p>Results obtained from multiple mutant lines converge to show that estrogen signaling, likely synthesized in the brain drives aspects of male sexual behavior.</p><p>The comparative discussion of the age-dependent abundance of brain aromatase in fish vs mammals and its role in organization vs activation is important beyond the study of the targeted species. - The authors have made important corrections to tone down some of the conclusions which are more in line with the results.</p></disp-quote><p>We thank the reviewer again for their positive evaluation of our work and the revisions we have made.</p><disp-quote content-type="editor-comment"><p>weaknesses:</p><p>No evaluation of the mRNA and protein products of Cyp19a1b and ESR2a are presented, such that there is no proper demonstration that the mutation indeed leads to aromatase reduction. The conclusion that these effects dependent on brain derived estrogens is therefore only supported by measures of E2 with an EIA kit that is not validated. No discussion of these shortcomings is provided in the discussion thus further weakening the conclusion manuscript.</p></disp-quote><p>In response to this and other comments, we have now provided direct validation that the cyp19a1b mutation in our medaka leads to loss of function. Real-time PCR analysis showed that cyp19a1b transcript levels in the brain were reduced by approximately half in cyp19a1b<sup>+/−</sup> males and were nearly absent in cyp19a1b<sup>−/−</sup> males, consistent with nonsense-mediated mRNA decay</p><p>In addition, AlphaFold 3-based structural modeling indicated that the mutant Cyp19a1b protein lacks essential motifs, including the aromatic region and heme-binding loop, and exhibits severe conformational distortion (see figure; key structural features are annotated as follows: membrane helix (blue), aromatic region (red), and heme-binding loop (orange)).</p><p>Results:</p><p>Line 101: The following text has been added: “Loss of cyp19a1b function was further confirmed by measuring cyp19a1b transcript levels in the brain and by predicting the three-dimensional structure of the mutant protein. Real-time PCR revealed that transcript levels were reduced by half in cyp19a1b<sup>+/−</sup> males and were nearly undetectable in cyp19a1b<sup>−/−</sup> males, presumably as a result of nonsense-mediated mRNA decay (Lindeboom et al., 2019) (Figure 1C). The wild-type protein, modeled by AlphaFold 3, exhibited a typical cytochrome P450 fold, including the membrane helix, aromatic region, and hemebinding loop, all arranged in the expected configuration (Figure 1—figure supplement 1C). The mutant protein, in contrast, was severely truncated, retaining only the membrane helix (Figure 1—figure supplement 1C). The absence of essential domains strongly indicates that the allele encodes a nonfunctional Cyp19a1b protein. Together, transcript and structural analyses consistently demonstrate that the mutation generated in this study causes a complete loss of cyp19a1b function.”</p><p>Materials and methods</p><p>Line 438: A subsection entitled “Real-time PCR” has been added. The text of this subsection is as follows: “Total RNA was isolated from the brains of cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males using the RNeasy Plus Universal Mini Kit (Qiagen, Hilden, Germany). cDNA was synthesized with the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, MA). Real-time PCR was performed on the LightCycler 480 System II using the LightCycler 480 SYBR Green I Master (Roche Diagnostics). Melting curve analysis was conducted to verify that a single amplicon was obtained in each sample. The β-actin gene (actb; GenBank accession number NM_001104808) was used to normalize the levels of target transcripts. The primers used for real-time PCR are shown in Supplementary file 2.”</p><p>Line 448: A subsection entitled “Protein structure prediction” has been added. The text of this subsection is as follows: “Structural predictions of Cyp19a1b proteins were conducted using AlphaFold 3 (Abramson et al., 2024). Amino acid sequences corresponding to the wild-type allele and the mutant allele generated in this study were submitted to the AlphaFold 3 prediction server. The resulting models were visualized with PyMOL (Schrödinger, New York, NY), and key structural features, including the membrane helix, aromatic region, and heme-binding loop, were annotated.”</p><p>References</p><p>The following two references have been added:</p><p>Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J, Bodenstein SW, Evans DA, Hung CC, O'Neill M, Reiman D, Tunyasuvunakool K, Wu Z, Žemgulytė A, Arvaniti E, Beattie C, Bertolli O, Bridgland A, Cherepanov A, Congreve M, CowenRivers AI, Cowie A, Figurnov M, Fuchs FB, Gladman H, Jain R, Khan YA, Low CMR, Perlin K, Potapenko A, Savy P, Singh S, Stecula A, Thillaisundaram A, Tong C, Yakneen S, Zhong ED, Zielinski M, Žídek A, Bapst V, Kohli P, Jaderberg M, Hassabis D, Jumper JM. 2024. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature <bold>630</bold>:493–500. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41586-024-07487-w">https://doi.org/10.1038/s41586-024-07487-w</ext-link></p><p>Lindeboom RGH, Vermeulen M, Lehner B, Supek F. 2019. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nature Genetics <bold>51</bold>:1645–1651. DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41588-019-0517-5">https://doi.org/10.1038/s41588-019-0517-5</ext-link></p><p>Figure 1</p><p>The real-time PCR results described above have been incorporated in Figure 1, panel C, with the corresponding legend provided below (line 788).</p><p>(C) Brain cyp19a1b transcript levels in cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males (n = 6 per genotype). Mean value for cyp19a1b<sup>+/+</sup> males was arbitrarily set to 1.</p><p>The subsequent panels have been renumbered accordingly. The entirety of the revised Figure 1.</p><p>Figure 1—figure supplement 1</p><p>The AlphaFold 3-generated structural models described above have been incorporated in Figure 1— figure supplement 1, panel C, with the corresponding legend provided below (line 811).</p><p>(C) Predicted three-dimensional structures of wild-type (left) and mutant (right) Cyp19a1b proteins. Key structural features are annotated as follows: membrane helix (blue), aromatic region (red), and heme-binding loop (orange).</p><p>The entirety of the revised Figure 1—figure supplement 1 is presented</p><p>The information on the primers used for real-time PCR has been included in Supplementary file 2.</p><p>The functional deficiency of esr2a was already addressed in the previous revision. For clarity, we have reproduced the relevant information here.</p><p>A previous study reported that female medaka lacking esr2a fail to release eggs due to oviduct atresia (Kayo et al., 2019, Sci Rep 9:8868). Similarly, in this study, some esr2a-deficient females exhibited spawning behavior but were unable to release eggs, although the sample size was limited (Δ8 line: 2/3; Δ4 line: 1/1). In contrast, this was not observed in wild-type females (Δ8 line: 0/12; Δ4 line: 0/11). These results support the effective loss of esr2a function. To incorporate this information into the manuscript, the following text has been added to the Materials and methods (line 423): “A previous study reported that esr2a-deficient female medaka cannot release eggs due to oviduct atresia (Kayo et al., 2019). Likewise, some esr2a-deficient females generated in this study, despite the limited sample size, exhibited spawning behavior but were unable to release eggs (Δ8 line: 2/3; Δ4 line: 1/1), while such failure was not observed in wild-type females (Δ8 line: 0/12; Δ4 line: 0/11). These results support the effective loss of esr2a function.”</p><disp-quote content-type="editor-comment"><p>Most experiments are weakly powered (low sample size).</p></disp-quote><p>This comment is essentially the same as one raised in the first review (Reviewer #3’s comment 7 on weaknesses). We acknowledge the reviewer’s concern that the histological analyses were weakly powered due to the limited sample size. In our earlier revision, we responded as follows:</p><p>Histological analyses were conducted with a relatively small sample size, as our previous experience suggested that interindividual variability in the results would not be substantial. Since significant differences were detected in many analyses, further increasing the sample size was deemed unnecessary.</p><disp-quote content-type="editor-comment"><p>The variability of the mRNA content for a same target gene between experiments (genotype comparison vs E2 treatment comparison) raises questions about the reproducibility of the data (apparent disappearance of genotype effect).</p></disp-quote><p>This comment is the same as one raised in the first review (Reviewer #3’s comment 8 on weaknesses), which we already addressed in our initial revision. For the reviewer’s convenience, we provide the response below:</p><p>As the reviewer pointed out, the overall area of ara expression is larger in Figure 2J than in Figure 2F. However, the relative area ratios of ara expression among brain nuclei are consistent between the two figures, indicating the reproducibility of the results. Thus, this difference is unlikely to affect the conclusions of this study.</p><p>Additionally, the differences in ara expression in pPPp and arb expression in aPPp between wild-type and cyp19a1b-deficient males appear less pronounced in Figures 2J and 2K than in Figures 2F and 2H. This is likely attributable to the smaller sample size used in the experiments for Figures 2J and 2K, resulting in less distinct differences. However, as the same genotype-dependent trends are observed in both sets of figures, the conclusion that ara and arb expression is reduced in cyp19a1b-deficient male brains remains valid.</p><disp-quote content-type="editor-comment"><p>Conclusions:</p><p>Overall, the claims regarding role of estrogens originating in the brain on male sexual behavior is supported by converging evidence from multiple mutant lines. The role of brain-derived estrogens on gene expression in the brain is weaker as are the results in females.</p></disp-quote><p>We appreciate the reviewer’s positive evaluation of our findings on male behavior. The concern regarding the role of brain-derived estrogens in gene expression has been addressed in our rebuttal, and the female data have been removed so that the analysis now focuses on males. The specific revisions for removing the female data are described in Response to reviewer #1’s comment 6 on weaknesses.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations For The Authors:</bold></p><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>The manuscript is improved slightly. I am thankful the authors addressed some concerns, but for several concerns the referees raised, the authors acknowledged them yet did not make corresponding changes to the manuscript or disagreed that they were issues at all without explanation. All reviewers had issues with the imbalanced focus on males versus females and the male aggression assay. Yet, they did not perform additional experiments or even make changes to the framing and scope of the manuscript. If the authors had removed the female data, they may have had a more cohesive story, but then they would still be left with inadequate behavior assays in the males. If the authors don't have the time or resources to perform the additional work, then they should have said so. However, the work would be incomplete relative to the claims. That is a key point here. If they change their scope and claims, the authors avoid overstating their findings. I want to see this work published because I believe it moves the field forward. But the authors need to be realistic in their interpretations of their data.</p></disp-quote><p>In response to this and related comments, we have removed the female data and focused the manuscript on analyses in males. The specific revisions are described in Response to reviewer #1’s comment 6 on weaknesses. Additionally, we have validated that the cyp19a1b mutation in our medaka leads to loss of function (see Response to reviewer #3’s comment 1 on weaknesses), which further strengthens the reliability of our conclusions regarding male behavior.</p><disp-quote content-type="editor-comment"><p>I agree with the reviewer who said we need to see validation of the absence of functional cyp19a1 b in the brain. However, the results from staining for the protein and performing in situ could be quizzical. Indeed, there aren't antibodies that could distinguish between aromatase a and b, and it is not uncommon for expression of a mutated gene to be normal. One approach they could do is measure aromatase activity, but they are *sort of* doing that by measuring brain E2. It's not perfect, but we teleost folks are limited in these areas. At the very least, they should show the predicted protein structure of the mutated aromatase alleles. It could show clearly that the tertiary structure is utterly absent, giving more support to the fact that their aromatase gene is non-functional.</p></disp-quote><p>As noted above, we have further validated the loss of cyp19a1b function by measuring cyp19a1b transcript levels in the brain and predicting the three-dimensional structure of the mutant protein. These analyses confirmed that cyp19a1b function is indeed lost, thereby increasing the reliability of our conclusions. For further details, please refer to Response to reviewer #3’s comment 1 on weaknesses.</p><disp-quote content-type="editor-comment"><p>With all of this said, the work is important, and it is possible that with a reframing of the impact of their work in the context of their findings, I could consider the work complete. I think with a proper reframing, the work is still impactful.</p></disp-quote><p>In accordance with this feedback, and as described above, we have reframed the manuscript by removing the female data and focusing exclusively on males. This revision clarifies the scope of our study and reinforces the support for our conclusions. For further details, please refer to Response to reviewer #1’s comment 6 on weaknesses.</p><disp-quote content-type="editor-comment"><p>(1) Clearly state in the Figure 1 legend that each data point for male aggressive behaviors represents the total # of behaviors calculated over the 4 males in each experimental tank.</p></disp-quote><p>In response to this comment, we have revised the legend of Figure 1K (line 797). The original legend, “(K) Total number of each aggressive act observed among cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, or cyp19a1<sup>−/−</sup> males in the tank (n = 6, 7, and 5, respectively),” has been updated to “(K) Total number of each aggressive act performed by cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males. Each data point represents the sum of acts recorded for the 4 males of the same genotype in a single tank (n = 6, 7, and 5 tanks, respectively).” This clarifies that each data point reflects the total behaviors of the 4 males within each tank.</p><disp-quote content-type="editor-comment"><p>(2) The authors wrote under &quot;Response to reviewer #1's major comment &quot;...the development of male behaviors may require moderate neuroestrogen levels that are sufficient to induce the expression of ara and arb, but not esr2b, in the underlying neural circuitry&quot;: &quot;This may account for the lack of aggression recovery in E2-treated cyp19a1b-deficient males in this study.&quot;.</p><p>What is meant by the latter statement? What accounts for the lack of aggression? The lack of increase in esr2b? Please clarify.</p></disp-quote><p>Line 365: In response to this comment, “This may account for the lack of aggression recovery in E2treated cyp19a1b-deficient males in this study.” has been revised to “Considering this, the lack of aggression recovery in E2-treated cyp19a1b-deficient males in this study may be explained by the possibility that the E2 dose used was sufficient to induce not only ara and arb but also esr2b expression in aggression-relevant circuits, which potentially suppressed aggression.”</p><p>This revision clarifies that, while moderate brain estrogen levels are sufficient to promote male behaviors via induction of ara and arb, the E2 dose used in this study may have additionally induced esr2b in circuits relevant to aggression, potentially underlying the lack of aggression recovery.</p><disp-quote content-type="editor-comment"><p>(3) This is a continuation of my comment/concern directly above. If the induction of ara and arb aren't enough, then how can, as the authors state, androgen signaling be the primary driver of these behaviors?</p></disp-quote><p>In response to this follow-up comment, we would like to clarify that, as described above, the lack of aggression recovery in E2-treated cyp19a1b-deficient males is not due to insufficient induction of ara and arb, but instead is likely because esr2b was also induced in aggression-relevant circuits, which may have suppressed aggression. Therefore, the concern that androgen signaling cannot be the primary driver of these behaviors is not applicable.</p><disp-quote content-type="editor-comment"><p>(4) The authors' point about sticking with the terminology for the ar genes as &quot;ara&quot; and &quot;arb&quot; is not convincing. The whole point of needing a change to match the field of neuroendocrinology as a whole (that is, across all vertebrates) is researchers, especially those with high standing like the Okubo group, adopt the new terminology. Indeed, the Okubo group is THE leader in medaka neuroendocrinology. It would go a long way if they began adopting the new terminology of &quot;ar1&quot; and &quot;ar2&quot;. I understand this may be laborious to a degree, and each group can choose to use their terminology, but I'd be remiss if I didn't express my opinion that changing the terminology could help our field as a whole.</p></disp-quote><p>We sincerely appreciate the reviewer’s thoughtful comments regarding nomenclature consistency in vertebrate neuroendocrinology. We understand the motivation behind the suggestion to adopt ar1 and ar2. However, we consider the established nomenclature of ara and arb to be more appropriate for the following reasons.</p><p>First, adopting the ar1/ar2 nomenclature would introduce a discrepancy between gene and protein symbols. According to the NCBI International Protein Nomenclature Guidelines (Section 2B.Abbreviations and symbols; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/genbank/internatprot_nomenguide/">https://www.ncbi.nlm.nih.gov/genbank/internatprot_nomenguide/</ext-link>), the ZFIN Zebrafish Nomenclature Conventions (Section 2. PROTEINS:<ext-link ext-link-type="uri" xlink:href="https://zfin.atlassian.net/wiki/spaces/general/pages/1818394635/ZFIN+Zebrafish+Nomenclature+Conventions">https://zfin.atlassian.net/wiki/spaces/general/pages/1818394635/ZFIN+Zebrafish+Nomenclature+Conventions</ext-link>), and the author guidelines of many journal (e.g.,<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/molehr/pages/Gene_And_Protein_Nomenclature">https://academic.oup.com/molehr/pages/Gene_And_Protein_Nomenclature</ext-link>), gene and protein symbols should be identical (with proteins designated in non-italic font and with the first letter capitalized). Maintaining consistency between gene and protein symbols helps avoid unnecessary confusion. The ara/arb nomenclature allows this, whereas ar1/ar2 does not.</p><p>Second, the two androgen receptor genes in teleosts are paralogs derived from the third round of wholegenome duplication that occurred early in teleost evolution. For such duplicated genes, the ZFIN Zebrafish Nomenclature Conventions (Section 1.2. Duplicated genes) recommend appending the suffixes “a” and “b” to the approved symbol of the human or mouse ortholog. This convention clearly indicates that these genes are whole-genome duplication paralogs and provides an intuitive way to represent orthologous and paralogous relationships between teleost genes and those of other vertebrates. As a result, it has been widely adopted, and we consider it logical and beneficial to apply the same principle to androgen receptors.</p><p>In light of these considerations, we respectfully maintain that the ara/arb nomenclature is more suitable for the present manuscript than the alternative ar1/ar2 system.</p><disp-quote content-type="editor-comment"><p>(5) In the discussion please discuss these potentially unexpected findings.</p><p>(a) gal was unaffected in female cyp19a1 mutants, but they exhibit mating behaviors towards females. Given gal is higher in males and these females act like females, what does this mean about the function of gal/its utility in being a male-specific marker (is it one??)?</p><p>(b) esr2b expression is higher in female cyp19a1 mutants. this is unexpected as well given esr2b is required for female-typical mating and is higher in females compared to males and E2 increases esr2b expression. please explain...well, what this means for our idea of what esr2b expression tell us.</p></disp-quote><p>We thank the reviewer for the insightful comments. As the female data have been removed from the manuscript, discussion of these findings in female cyp19a1b mutants is no longer necessary.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>The authors have addressed a number of answers to the reviewer's comments, notably they provided missing methodological information and rephrased the text. However, the authors have not addressed the main issues raised by the reviewers. Notably, it is regrettable that the reduced amount of brain aromatase cannot be confirmed, this seems to be the primary step when validating a new mutant. Even if protein products of the two genes may not be discriminated (which I can understand), it should be possible to evaluate the expression of a common messenger and/or peptide and confirm that aromatase expression is reduced in the brain. Since Cyp19a1b is relatively more abundant in the brain Cyp19a1a, this would strengthen the conclusion and provide confidence that the mutant indeed does silence aromatase expression in the brain. Although these short comings are acknowledged in the rebuttal letter, this is not mentioned in the discussion. Doing so would make the manuscript more transparent and clearer.</p></disp-quote><p>As noted in Response to reviewer #3’s comment 1 on weaknesses, we have validated the loss of Cyp19a1b function by measuring its transcript levels in the brain and predicting the three-dimensional structure of the mutant protein. These analyses confirmed that Cyp19a1b function is indeed lost, thereby increasing the reliability of our conclusions.</p><disp-quote content-type="editor-comment"><p>FigS1 - panels C&amp;D please indicate in which tissue were hormones measured. Blood?</p></disp-quote><p>We thank the reviewer for pointing this out. In our study, “peripheral” refers to the caudal half of the body excluding the head and visceral organs, not blood. Accordingly, we have revised the figure legend and the description in the Materials and Methods section as follows:</p><p>Legend for Figure 1B (line 787) now reads: “Levels of E2, testosterone, and 11KT in the brain (A) and peripheral tissues (caudal half of the body) (B) of adult cyp19a1b<sup>+/+</sup>, cyp19a1b<sup>+/−</sup>, and cyp19a1b<sup>−/−</sup> males (n = 3 per genotype).”</p><p>Materials and methods (line 431): The sentence “Total lipids were extracted from the brain and peripheral tissues (from the caudal half) of” has been revised to “Total lipids were extracted from the brain and from peripheral tissues, specifically the caudal half of the body excluding the head and visceral organs, of.”</p><p>Additional Alterations:</p><p>We have reformatted the text and supporting materials to comply with the journal’s Author Guidelines. The following changes have been made:</p><p>(1) Figures and supplementary files are now provided separately from the main text.</p><p>(2) The title page has been reformatted without any changes to its content.</p><p>(3) In-text citations have been changed from numerical references to the author–year format.</p><p>(4) Figure labels have been revised from “Fig. 1,” “Fig. S1,” etc., to “Figure 1,” “Figure 1—figure supplement 1,” etc.</p><p>(5) Table labels have been revised from “Table S1,” etc., to “Supplementary file 1,” etc.</p><p>(6) Line 324: The typo “is” has been corrected to “are”.</p><p>(7) Line 382: The section heading “Materials and Methods” has been changed to “Materials and methods” (lowercase “m”).</p><p>(8) Line 383: The Key Resources Table has been placed at the beginning of the Materials and methods section.</p><p>(9) Line 389: The sentence “Sexually mature adults (2–6 months) were used for experiments, and tissues were consistently sampled 1–5 hours after lights on.” has been revised to “Sexually mature adults (2–6 months) were used for experiments and assigned randomly to experimental groups. Tissues were consistently sampled 1–5 hours after lights on.”</p><p>(10) Line 393: The sentence “All fish were handled in accordance with the guidelines of the Institutional Animal Care and Use Committee of the University of Tokyo.” has been removed.</p><p>(11) Line 589: The following sentence has been added: “No power analysis was conducted due to the lack of relevant data; sample size was estimated based on previous studies reporting inter-individual variation in behavior and neural gene expression in medaka.”</p><p>(12) Line 598: The reference list has been reordered from numerical sequence to alphabetical order by author.</p><p>(13) In the figure legends, notations such as “A and B” have been revised to “A, B.”</p></body></sub-article></article>